Page last updated: 2024-08-18

cyclohexanol and Depression, Involutional

cyclohexanol has been researched along with Depression, Involutional in 495 studies

Research

Studies (495)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (3.03)	18.2507
2000's	259 (52.32)	29.6817
2010's	213 (43.03)	24.3611
2020's	8 (1.62)	2.80

Authors

Authors	Studies
Aldosary, F; Blier, P; James, JS; Norris, S; Ritchie, JC; Tremblay, P	1
Coutens, B; Guiard, BP; Rampon, C; Yrondi, A	1
Bansal, R; Chen, Y; Hellerstein, DJ; Peterson, BS; Sawardekar, S	1
Croarkin, PE; Mills, JA; Strawn, JR; Suresh, V	1
Asami, Y; Boucher, M; Kato, M; Pappadopulos, E; Prieto, R; Wajsbrot, DB; Wang, X	1
Gündüz, Ş; Kandeğer, A; Selvi, Y	1
Norman, TR; Olver, JS	1
Boyce, P; Chen, R; Feng, L; Hu, Y; Shi, H; Wang, G; Wang, X; Xiao, L; Yang, R; Zhou, J; Zhu, X	1
Lai, CH	1
Berk, M; Bousman, CA; Byron, K; Ng, CH; Singh, AB	2
Boyer, P; Hwang, E; Rosenthal, JZ; Tourian, KA; Vialet, C	1
Andrade, C	1
Huang, X; Ji, JL; Li, C; Luo, YL; Wang, B	1
Hwang, E; Liebowitz, MR; Mele, L; Tourian, KA	1
Dorries, KM; Dunner, DL; Gelenberg, AJ; Ninan, PT; Pedersen, R; Rothschild, AJ	1
Begley, AE; Blumberger, D; Butters, M; Dew, MA; Joel, I; Lenze, EJ; Mazumdar, S; Mulsant, BH; Reynolds, CF	1
Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C	1
Ii, Y; Tourian, K; Wang, Y	1
Chang, HH; Chen, PS; Chi, MH; Gean, PW; Lee, IH; Lu, RB; Tsai, HC; Yang, YK	1
Geber, C; Hiemke, C; Ostad Haji, E; Schlicht, K; Tadić, A	1
Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A	1
Hopkins, SC; Koblan, KS; Reasner, DS	1
Angelo, LJ; Lee, KC	1
Birkenhäger, TK; Bruijn, JA; Mulder, PG; van den Broek, WW; Vermeiden, M	1
Etkin, A; Gordon, E; Grieve, SM; Harris, A; Korgaonkar, MS; Koslow, SH; Nemeroff, CB; Schatzberg, AF; Williams, LM; Wisniewski, S	1
Culpepper, L; Fayyad, RS; Guico-Pabia, CJ; Musgnung, J; Papakostas, GI	1
Gibiino, S; Marsano, A; Serretti, A	1
Chen, Y; Faries, DE; Lipkovich, I; Liu, X; Obenchain, RL; Zagar, A	1
Aarya, KR; Grover, S; Sharma, A	1
Bousman, C; Byron, K; Ng, C; Peh, LH; Sarris, J; Schweitzer, I; Singh, A; Smith, DJ; Tan, CH	1
Civitelli, R; Dixon, D; Garfield, LD; Kennedy, JL; Lenze, EJ; Müller, DJ; Mulsant, BH; Reynolds, CF; Teitelbaum, SL; Todorov, AA	1
Eurviriyanukul, K; Maneeton, B; Maneeton, N; Srisurapanont, M	1
Bognár, Z; Gazdag, G; Vonyik, G	1
Abrams, M; Cook, IA; Hunter, AM; Leuchter, AF	2
Miller, MC	1
Davidson, RJ; Heller, AS; Johnstone, T; Kalin, NH; Kolden, GG; Peterson, MJ	1
Bao, W; Clayton, AH; Dunlop, BW; Focht, K; Kornstein, SG; Musgnung, J; Ninan, PT; Ramey, T	1
Berk, M; Bousman, CA; Ng, CH; Singh, AB	1
de Bodinat, C; Lejoyeux, M; Matharan, S	1
Holland, PJ; Keller, MB; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Thase, ME; Trivedi, MH	1
Fayyad, RS; Guico-Pabia, CJ; Soares, CN	2
Bonnet, U; Khalil-Boutros, Y	1
Bao, W; Clayton, A; Guico-Pabia, CJ; Kornstein, SG	1
Ellis, N; Garcia, A; Nakama, H; O'Brien, K	1
Alberti, S; Chiesa, A; Han, C; Lee, SJ; Lia, L; Pae, CU; Patkar, AA; Serretti, A	1
Boucher, M; Endicott, J; Fayyad, RS; Guico-Pabia, CJ; Soares, CN	1
Boucher, M; Endicott, J; Fayyad, R; Guico-Pabia, C; Hsu, MA; Lam, RW	1
Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS	1
Jain, S	1
Chiles, D; Findling, RL; Groark, J; Ramaker, S; Tourian, KA; Yang, L	1
Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S	1
Bellomo, G; Dalò, V; Gramaglia, C; Meola, S; Pollarolo, P; Prosperini, P; Ressico, F; Rolla, R; Torre, E; Vidali, M; Zeppegno, P	1
Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Novak, T; Sos, P; Stopkova, P	1
Buckley, G; Khan, A; Messig, M; Musgnung, J; Ninan, PT; Ramey, T	1
Choi, TK; Kim, B; Lee, MH; Lee, SH	1
Boucher, M; Kornstein, SG; McIntyre, RS; Thase, ME	1
Newton, KM	1
Boucher, M; Endicott, J; Fayyad, R; Guico-Pabia, CJ; Hsu, MA; Lam, RW	1
Groppe, S; Gründer, G; Hiemke, C; Paulzen, M; Tauber, SC; Veselinovic, T	1
Fayyad, RS; Guico-Pabia, CJ; Kornstein, SG	1
Chang, YH; Chen, PS; Chen, SH; Chen, SL; Cheng, LY; Chu, CH; Chuang, HY; Lee, IH; Lu, RB; Wang, YS; Yang, YK; Yeh, TL	1
Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S	1
Deckert, J; Hempel, S; Kopf, J; Olmes, D; Pfuhlmann, B; Proft, F; Reif, A; Riederer, P; Schmidt, B; Unterecker, S	1
Bouckaert, F; Kho, KH; Kok, RM; Sienaert, P; Spaans, HP; Stek, ML; van den Berg, JF; Verwijk, E	2
Birkenhäger, TK; Kamperman, AM; van den Broek, WW; Vermeiden, M; Vulink, ME	1
Cheng, RF; Clayton, AH; Focht, K; Hwang, E; Thase, ME; Tourian, KA	1
Chen, CY; Hung, CI; Liu, CY; Wang, SJ; Yang, CH	1
Deuschle, M; Gilles, M; Gronau, W; Lederbogen, F; Paslakis, G; Schilling, C; Weber-Hamann, B	1
Bombardier, CH; Fann, JR; Forchheimer, M; Heinemann, AW; Neumann, HD; Tate, DG	1
Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR	1
Chen, CJ; Chen, CY; Ho, PS; Huang, SY; Jang, FL; Kuo, SC; Liang, CS; Lu, RB; Shyu, JF; Wan, FJ; Yeh, YW; Yen, CH	1
Barber, JK; Bombardier, CH; Brooks, L; Chiodo, AE; Fann, JR; Heinemann, AW; McCullumsmith, C; Richards, JS; Tate, DG; Temkin, NR; Wilson, CS	1
Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM	1
Bombardier, CH; Brooks, L; Fann, JR; Heinemann, AW; McCullumsmith, CB; Richards, JS; Tate, DG; Temkin, NR; Warms, C; Warren, AM; Wilson, CS	1
Geduldig, ET; Greenberg, RM; Husain, MM; Kellner, CH; Knapp, RG; Lisanby, SH; McCall, WV; Petrides, G; Prudic, J; Rudorfer, MV; Weiner, RD; Young, RC	1
Filippov, G; Gislum, M; Montgomery, S; Wang, G	1
Boucher, M; Cheng, RF; Fayyad, R; Guico-Pabia, CJ; Sporn, J; Thase, ME; Tourian, KA	1
Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM	1
DeBattista, C; Etkin, A; Lazzeroni, LC; Murphy, GM; Schatzberg, AF; Williams, LM	1
Bao, W; Clayton, AH; Guico-Pabia, CJ; Kornstein, SG	1
Chen, J; Gong, W; Li, Z; Mu, J; Shao, W; Wu, Q; Xie, P; Xu, F; Yang, D; Yang, J; Yang, Y; Zhang, J	1
Ivanets, NN; Iziumina, TA; Kinkulkina, MA; Tikhonova, YG	1
Emilsson, JF; Eriksson, E; Hieronymus, F; Nilsson, S	1
Aydin, A; Boysan, M; Güzel Özdemir, P; Selvi, Y; Smolensky, MH; Yilmaz, E	1
Kripke, DF	1
Lewy, AJ	1
McMahon, FJ	1
Sher, L	1
Ganguly, R; Liebowitz, MR; Manley, AL; Padmanabhan, SK; Tourian, KA; Tummala, R	1
Bonaccorso, S; Girardi, P; Matrisciano, F; Nicoletti, F; Panaccione, I; Ricciardi, A; Ruberto, A; Scaccianoce, S; Shelton, RC; Tatarelli, R; Wang, L	1
Gourion, D	1
Anderson, IM; Haddad, PM; Tint, A	1
Brisard, C; Germain, JM; Lieberman, DZ; Montgomery, SA; Padmanabhan, K; Pitrosky, B; Rosas, G; Tourian, KA	1
Khandker, RK; Kruzikas, DT; McLaughlin, TP	1
de Abajo, FJ; García-Rodríguez, LA	1
Chrzanowski, W; Gee, M; Hewett, K; Krishen, A; Leary, MO; Milanova, V; Millen, L; Modell, J; Savela, A; Schmitz, M	1
Harrison, C; Lane, C; Steen, N; Vanoli, A; Young, A	1
Carrier, EJ; Gorzalka, BB; Hill, MN; Hillard, CJ; McLaughlin, RJ; Meier, SE; Morrish, AC	1
Preskorn, SH	2
Lohoff, FW; Rickels, K	1
Katona, C	1
Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Kim, YK; Lee, HY	1
Jureidini, J; Mintzes, B	1
Amsterdam, JD; Shults, J	1
Ehret, MJ; Grgas, M; Sopko, MA	1
Dekker, J; Peen, J; Schoevers, RA; van Aalst, G; Van, HL	1
Boyer, P; Brisard, C; Ganguly, R; Germain, JM; Lepola, U; Montgomery, S; Padmanabhan, SK; Tourian, KA	1
Millet, B	1
Buitelaar, JK; Roobol, TH	1
Kaplan, P; Kora, K	1
Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B	1
Hazra, M; Pollock, BG; Sproule, BA	1
Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V	1
Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K	1
Cunha, FT; Ladeira, RB; Nicolato, R; Salgado, JV; Teixeira, AL	1
Bunchapattanasakda, C; Kongsakon, R	1
Ahmed, S; Dunlop, BW; Friedman, ES; Keller, M; Kocsis, JH; Kornstein, SG; Li, T; Ninan, PT; Pedersen, R; Thase, M; Yan, B	1
Plosker, GL; Yang, LP	1
Chen, CH; Lu, ML	1
Heeren, TJ; Kok, RM; Nolen, WA	2
Guico-Pabia, CJ; Helzner, EC; Nichols, AI; Patroneva, AL; Paul, J; Preskorn, SH	1
Cook, IA; Hunter, AM; Leuchter, AF; Ravikumar, S	1
Handratta, V; Kamath, J	1
Han, C; Marks, DM; Masand, PS; Pae, CU; Park, MH; Patkar, AA	1
Bahk, WM; Chae, JH; Jun, TY; Jung, YE; Seo, HJ; Woo, YS	1
Bauer, M; Freemantle, N; Moeller, HJ; Tharmanathan, P; Volz, HP	1
Hollander, E	1
Feiger, AD; Padmanabhan, SK; Rosas, GR; Tourian, KA	1
Kyomen, HH; Whitfield, TH	1
Butters, MA; Dew, MA; Driscoll, HC; Lenze, EJ; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Sheffrin, M	1
Asarnow, J; Birmaher, B; Brent, DA; Clarke, GN; Debar, LL; Emslie, GJ; Iyengar, S; Keller, MB; Kennard, B; Leonard, H; Mayes, TL; McCracken, JT; Onorato, M; Porta, G; Ritz, L; Ryan, ND; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Zelazny, J	1
Entsuah, R; Nemeroff, CB; Sheehan, DV; Thase, ME	1
Arocha, L; Fazzino, F; Lima, L; Mata, S; Morles, M; Obregón, F; Rojas, A	1
Hung, CI; Liu, CY; Wang, SJ	1
Burslem, K; Greenstreet, L; Knight, C; Lenox-Smith, A	1
Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Kozeny, J; Novak, T; Sos, P; Stopkova, P	1
Bauer, M; Jiang, Q; Loeschmann, PA; Moeller, HJ; Ninan, PT; Schmitt, AB; Volz, HP	1
Caykoylu, A; Ekinci, O; Kuloglu, M	1
Campbell, GM; Case, M; Corya, SA; Henley, DB; Osuntokun, O; Thase, ME; Trivedi, MH; Watson, SB	1
Brown, L; Eliasziw, M; Lavorato, DH; McLaren, L; Patten, SB; Williams, JV	1
Heeren, TJ; Kok, RM; Nolen, WA; van Baarsen, C	1
Bukh, JD; Dam, H; Jørgensen, MB; Plenge, P	1
Pae, CU	2
Spadone, C	1
Dekker, J; Hendriksen, M; Koelen, J; Kool, S; Peen, J; Schoevers, R; van Aalst, G; Van, HL	1
Avissar, S; Golan, M; Matuzany-Ruban, A; Miroshnik, N; Schreiber, G	1
Ash, P; Jacob, MK	1
Germain, JM; Guico-Pabia, C; Jiang, Q; Kornstein, SG; Ninan, PT; Thase, ME	1
Clayton, AH; Guico-Pabia, C; Kornstein, SG; Rosas, G; Tourian, KA	1
Hassan, M; Marcus, SC; Olfson, M	1
Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR	1
Bieling, PJ; Kennedy, SH; Konarski, JZ; Lau, MA; Mayberg, HS; McIntyre, RS; Segal, ZV	2
Amsterdam, J; Hilbe, JM; Kim, H; Shults, J; Sun, W; Ten-Have, T; Tu, X	1
Becker, T; Koesters, M; Weinmann, S	2
Kodaka, F; Koga, M; Miyata, H; Nakayama, K	1
Alpert, JE; Denninger, JW; Devlin, P; Fava, M; Greenwald, S; Iosifescu, DV; Mischoulon, D	1
Cooper, T; Dillingham, EM; Garcia, K; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, P; Sackeim, HA	1
Cook, IA; Hunter, AM; Leuchter, AF; Muthén, BO	1
Baker, RA; Berman, RM; Carlson, BX; Eudicone, JM; Mankoski, R; Nelson, JC; Pikalov, A; Tran, QV	1
Bakish, D	1
Andersen, HF; Kornstein, SG; Larsson, S; Li, D; Mao, Y; Papakostas, GI	1
Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A	1
Amsterdam, JD; Shults, J; Wang, G	1
Chung, SK; Hong, JP; Kang, EH; Kim, EJ; Kim, S; Lee, IS; Lee, SY; Oh, KS; Park, JE; Woo, JM; Yu, BH	1
Cassagnol, M; Perry, R	1
Brisard, C; Farrington, D; Groark, J; Padmanabhan, SK; Tourian, KA	1
Deuschle, M; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Lewicka, S; Onken, V; Römer, B; Schilling, C	1
Fava, M; Jiang, Q; Kornstein, SG; Tourian, KA	1
Dunlop, BW; Dunner, DL; Friedman, ES; Gelenberg, A; Goldstein, C; Holland, P; Keller, MB; Kocsis, JH; Kornstein, SG; Pedersen, R; Rothschild, AJ; Shelton, R; Thase, ME; Trivedi, MH; Zajecka, JM	1
Fava, M; Guico-Pabia, CJ; Montgomery, SA; Padmanabhan, SK; Tourian, KA	1
Brent, DA	1
Başterzi, AD; Buturak, V; Cimen, B; Eskandari, G; Taşdelen, B; Tot Acar, S; Yazici, A; Yazici, K	1
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Goldstein, BI; Mayes, T; Onorato, M; Ryan, N; Shamseddeen, W; Spirito, A; Vitiello, B; Wagner, KD; Zelazny, J	1
Birkenhäger, TK; Boks, MP; Breteler, LM; Bruijn, JA; Burger, H; Janzing, JG; Nolen, WA; van den Broek, WW; van der Loos, ML; Verkes, RJ; Wijkstra, J	1
Fava, M; Gaynes, BN; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ	1
Guico-Pabia, CJ; Jiang, Q; Kornstein, SG; Soares, CN; Thase, ME	1
Guico-Pabia, CJ; Kane, C; Musgnung, J; Ninan, PT; Pitrosky, B; Reddy, S	1
Baune, BT; Caliskan, S; Todder, D	2
Grønli, O; Olstad, R; Stensland, GØ; Wynn, R	1
Devane, CL; Fareed, J; Halaris, A; Hoppensteadt, D; Iqbal, O; Piletz, JE; Sinacore, J; Zhu, H	1
Evoniuk, G; Gee, MD; Hewett, K; Krishen, A; Le Clus, A; Modell, JG; Wunderlich, HP	1
Bonelli, RM; Holl, AK; Holl, EM; Painold, A; Wilkinson, L	1
Gourion, D; Montagne, A; Olié, JP; Poirier, MF; Rostin, M	1
Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE	1
Brisard, C; Germain, JM; Guelfi, JD; Leurent, C; Montgomery, SA; Padmanabhan, SK; Pitrosky, B; Rickels, K; Tourian, KA	1
Angermeier, T; Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B; Westphal, S	1
Kahn, DA; Kalia, R; Khan, AY; Magsalin, RM	1
Amara, G; Ben Hadj Ali, B; Ben Nasr, S; Saada, W	1
Rush, AJ	2
Dunlop, BW; Friedman, ES; Keller, M; Kornstein, SG; Li, T; Ninan, P; Pedersen, R; Rothschild, AJ	1
Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J	1
Despiégel, N; Lam, RW; Lönn, SL	1
Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C; Weber-Hamann, B	1
Jiang, Q; Ninan, PT; Tourian, KA	1
Clayton, AH; Guico-Pabia, CJ; Kornstein, SG; Padmanabhan, SK; Soares, CN	1
Regestein, QR	1
Dunner, DL; Friedman, ES; Gelenberg, A; Keller, MB; Kocsis, JH; Kornstein, SG; Rothschild, AJ; Shelton, RC; Thase, ME; Trivedi, MH; Zajecka, JM	1
Clayton, A; Cohen, LS; Focht, K; Guico-Pabia, CJ; Jiang, Q; Kane, CP; Kornstein, SG; Ninan, P; Soares, CN; Thase, ME	1
Caratan, S; Mihanović, M; Presecki, P; Silić, A; Vuina, AL	1
Cao, L; Chen, J; Cui, X; Fang, Y; Gao, K; Hong, W; Jiang, K; Nierenberg, AA; Wang, Y; Wu, Z; Xu, Y; Yi, Z; Yuan, C	1
Groark, J; Ninan, PT; Padmanabhan, K; Tourian, KA	1
Heeren, T; Kok, R; Nolen, W	1
Deuschle, M; Gilles, M; Paslakis, G	1
Dolder, C; Nelson, M; Stump, A	1
Choi, TK; Kim, SJ; Lee, E; Lee, HS; Lee, SH; Seok, JH	1
Chang, HH; Chen, PS; Chi, MH; Gean, PW; Lee, IH; Lee, SY; Lu, RB; Yang, YK	1
Danchenko, N; Despiegel, N; Maman, K; Marteau, F; Nordström, G	1
Guico-Pabia, CJ; Jiang, Q; Kornstein, SG; Musgnung, JJ; Reddy, S	1
Gelenberg, A; Keller, M; Kocsis, JH; Kornstein, SG; Li, T; Ninan, P; Pedersen, R; Thase, ME; Trivedi, MH	1
Bech, P; Boyer, P; Germain, JM; Haudiquet, V; Padmanabhan, K; Pitrosky, B; Tourian, KA	1
Becker, T; Grouven, U; Kaiser, T; Kerekes, MF; Koesters, M; Kreis, J; Kromp, M; Schueler, YB; Weinmann, S; Wieseler, B	1
Plesnicar, BK	1
Agius, M; Bugler, R; Tavormina, G; Zaman, R	1
Bokde, AL; Brückmann, H; Frodl, T; Hampel, H; Koutsouleris, N; Linn, J; Meisenzahl, E; Möller, HJ; Scheuerecker, J; Schoepf, V; Wiesmann, M	1
Raj, YP	1
Chang, HH; Chen, PS; Chi, MH; Gean, PW; Lu, RB; Wang, HC; Yang, YK; Yeh, TL	1
Blanca-Tamayo, M; Gimeno-de la Fuente, V; Navarro-Artieda, R; Salvatella-Pasant, J; Sicras-Mainar, A	1
Lobello, K; Musgnung, J; Ninan, PT; Pedersen, R; Reddy, S	1
Cook, IA; Hunter, AM; Leuchter, AF	2
Nichols, AI; Paul, J; Tourian, KA; Tse, SY	1
Chang, JP; Su, KP; Wu, CC	1
Brotchie, HL; Hyett, M; Parker, GB	1
Chaney, A; Frodl, T; Lisiecka, D; Meisenzahl, E; Moeller, HJ; Scheuerecker, J; Schoepf, V; Whitty, P; Wiesmann, M	1
Haskett, R; Isenberg, K; Kimball, J; Lasater, B; McCall, WV; Prudic, J; Rosenquist, PB; Sackeim, HA	1
Cooper, NJ; Gordon, E; Koslow, SH; Nemeroff, CB; Rush, AJ; Schatzberg, AF; Williams, LM; Wisniewski, SR	1
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; DeBar, L; Dickerson, J; Emslie, G; Iyengar, S; Keller, MB; Kennard, B; Lynch, F; Mayes, TL; McCracken, JT; Onorato, M; Porta, G; Ryan, ND; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD; Zelazny, J	1
Robinson, RL; Swindle, RW; Ye, W; Zhao, Y	1
Angermeier, T; Deuschle, M; Gilles, M; Hummel, J; Kopf, D; Lederbogen, F; Luley, C; Weber-Hamann, B; Westphal, S	1
Clayton, A; Focht, K; Guico-Pabia, CJ; Jiang, Q; Kane, CP; Kornstein, SG; Ninan, PT; Soares, CN; Thase, ME	1
Liang, CS; Yang, FW	1
Ancock, B; Cuevas, C; Lung, D; Zaid, U	1
Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Dickerson, JF; Emslie, G; Iyengar, S; Keller, MB; Kennard, B; Lynch, FL; Mayes, T; McCracken, JT; Onorato, M; Porta, G; Ryan, ND; Spirito, A; Strober, M; Suddath, RL; Vitiello, B; Wagner, KD; Zelazny, J	1
Ben-Hamadi, R; Dworak, H; Erder, MH; Ramakrishnan, K; Signorovitch, J; Wu, EQ; Yu, AP	1
Rakun, R; Ružić, K; Sabljić, V	1
Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; Emslie, G; Goldstein, T; Keller, MB; Mayes, T; Perel, J; Porta, G; Ryan, ND; Sakolsky, D; Wagner, KD; Woldu, H	1
Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Cook, IA; Hunter, AM; Korb, AS; Leuchter, AF	1
Liu, X; Mullins, CD; Wang, J	1
Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Fiedler, JL; Fritsch, R; Jara, P; Rojas, PS; Rojas, RA	1
Brooks, WB	1
Barak, Y; Baruch, Y; Swartz, M	1
Bahk, WM; Jun, TY; Jung, YE; Kim, KS	1
Alvarez, E; Artigas, F; Dragheim, M; Loft, H; Perez, V	1
Guico-Pabia, CJ; Jiang, Q; Ninan, PT; Thase, ME	1
Davidson, RJ; Heller, AS; Johnstone, T; Kalin, NH; Kolden, GG; Light, SN; Peterson, MJ	2
Dunlop, BW; Focht, K; Guico-Pabia, CJ; Lubaczewski, S; Reddy, S; Yang, L	1
Garakani, A; Gorman, JM; Martinez, JM; Yehuda, R	2
Shemesh, E	1
Lerman, A	1
de Silva, VA; Hanwella, R	1
Alexander, R; Archer, G; Evoniuk, G; Graff, O; Krishnan, KR; Lavergne, A; Learned, S; Moate, R; Modell, JG; Ratti, E; Roychowdhury, S; Zamuner, S	1
Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Frölich, L; Hausner, L; Janke, C; Kranaster, L; Sartorius, A	1
Barber, JP; Barrett, MS; Gallop, R; Rickels, K; Rynn, MA	1
Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T	1
Hung, CI; Liu, CY; Wang, SJ; Yang, CH	1
Asarnow, JR; Brent, D; Clarke, G; Emslie, GJ; Iyengar, S; Keller, M; Onorato, M; Porta, G; Ritz, L; Ryan, N; Vitiello, B; Wagner, KD; Zelanzny, J	1
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, GJ; Keller, MB; Porta, G; Ryan, N; Shamseddeen, W; Wagner, KD	1
Brown, CH; Davis, J; Gibbons, RD; Hur, K; Mann, JJ	1
Kocsis, JH	1
Barbini, B; Benedetti, F; Colombo, C; Dallaspezia, S; Fulgosi, MC; Gavinelli, C; Smeraldi, E	1
Brown, CH; Davis, JM; Gibbons, RD; Hur, K; Mann, JJ	3
Weder, N	1
Rubin, DH	1
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Dickerson, JF; Dietz, LJ; Emslie, G; Keller, M; Kennard, B; Lynch, FL; Mayes, T; McMakin, DL; Olino, TM; Porta, G; Ryan, ND; Shamseddeen, W; Spirito, A; Wagner, KD	1
Bech, P; Lunde, M; Martiny, K; Plenge, P	1
Bao, W; Dunlop, BW; Holland, P; Keller, MB; Ninan, PT	1
Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G	1
Chiang, KT; Ho, PS; Liang, CS; Su, HC	1
Chen, J; Cui, D; Fang, Y; Hong, W; Li, Z; Qi, D; Wang, Z; Yi, Z; Yu, S; Yuan, C; Zhang, C	1
Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR	1
Abbass, AA; Shedler, J; Town, JM	1
Chang, JS; Ha, K; Ha, TH; Her, JY; Park, T; Yi, SH; Yoo, CS; Yoon, IY	1
De Berardis, D; Di Giannantonio, M; Di Iorio, G; Di Nicola, M; Gambi, F; Janiri, L; Martinotti, G; Onofrj, M; Sepede, G	1
Deuschle, M; Gilles, M; Gronau, W; Kopf, D; Lecei, O; Lederbogen, F; Roth, HJ; Scharnholz, B; Schilling, C; Terhardt, J; Weber-Hamann, B	1
Schwartz, TL	1
Ferguson, JM; Rosas, GR; Tourian, KA	1
Canny, LM; Coleman, KA; Meaney, JV; Palmer, TL; Radalj, LM; Xavier, VY	1
Clayton, AH; Fayyad, R; Focht, K; Musgnung, J; Reddy, S	1
Leelahanaj, T	1
Deuschle, M; Gilles, M; Hellweg, R; Lang, UE; Lederbogen, F; Scharnholz, B	1
Auchincloss, EL; Occhiogrosso, M	1
Fava, M; Perlis, RH; Perroud, N; Uher, R	1
Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S	1
Cruz, R; Dennison, EA; Raidoo, BM; Raidoo, D	1
Adams, J; Graves, N; Solomon, D	1
Agosti, V; Bisaga, A; Brooks, DJ; Carpenter, KM; Levin, FR; Mariani, J; Nunes, EV; Pavlicova, M; Sullivan, MA	1
Healy, D; Jureidini, J; Purssey, R; Spielmans, GI	1
Carroll, BJ	1
Brus, O; Carlborg, A; Engström, I; Ljung, T; Nordenskjöld, A; von Knorring, L	1
Hwang, E; Iwata, N; Mele, L; Tourian, KA; Vialet, C	1
Civitelli, R; Dixon, D; Doré, P; Garfield, LD; Lenze, EJ; Mulsant, BH; Reynolds, CF; Shea, ML; Teitelbaum, S	1
Kaplan, EM	1
Cantillon, M; Davidson, JR; Hackett, D; Haudiquet, V; Meoni, P	1
Berigan, T	1
Frare, F; Perugi, G; Ruffolo, G; Toni, C; Torti, C	1
Arias, F; Carrasco, JL; Chamorro, L; Díaz-Marsá, M; Ferrando, L; Ibáñez, A; Jordá, L; Martín-Ballesteros, E; Martín-Carrasco, M; Montes, JM; Padín, J; Sáiz-Ruiz, J	1
Thase, ME; Trivedi, M	1
Artigas, F; Nutt, DJ; Shelton, R	1
Ansseau, M; Charlier, C; Pinto, E; Plomteux, G	1
Anderle, MJ; Davidson, RJ; Irwin, W; Kalin, NH	1
Haack, M; Hinze-Selch, D; Koethe, D; Kraus, T; Pollmächer, T; Schuld, A	1
Gastó, C; Marcos, T; Navarro, V; Portella, MJ; Rodamilans, M; Torra, M	1
Casciano, R	1
Burrows, GD; Gupta, RK; Tiller, JW	1
Malek-Ahmadi, P	1
Dierkes, W; Huppertz-Helmhold, S; Sauer, H	1
Hwang, JP; Tsai, SJ; Yang, CH	1
Fountoulakis, KN; Iacovides, A; St Kaprinis, G	1
Entsuah, R; Hackett, D; Kunz, NR; Montgomery, SA; Rudolph, RL	1
Albano, D; Grothe, DR; Scheckner, B	1
Alamo, C; López-Muñoz, F; Rubio, G; San, L	1
Baboolal, NS	1
Azen, SP; Chou, CP; James Gauderman, W; Leuchter, AF; Marie-Mitchell, A	1
Carnes, CA; Pickworth, KK; Raman, SV; Votolato, NA	1
Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ	1
Pavlovic, ZM	1
Buchkremer, G; Laske, C; Leyhe, T; Wormstall, H	1
Courtney, DB	1
Goodman, M; Grossman, R; Mitropoulou, V; New, A; Reynolds, D; Schmeidler, J; Siever, LJ; Silverman, J	1
Chamberlain, JC; Jones, L; Weiss, NT	1
Allard, P; Behnke, K; Gram, L; Hanson, M; Søgaard, J; Timdahl, K	1
Alpert, JE; Bottiglieri, T; Burns, A; Fava, M; Mahal, Y; Mischoulon, D; Nierenberg, AA; Papakostas, G; Petersen, T; Worthington, JJ	1
Albano, D; Zajecka, JM	1
Shelton, CI	1
Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM	1
Aydemir, O; Deveci, A; Taneli, F	1
Lange, CL	1
Carey, TS; Gartlehner, G; Gaynes, BN; Hansen, RA; Lohr, KN; Randolph, LC	1
Fernandez, JL; Francois, C; Montgomery, S	1
Annemans, L; Demyttenaere, K; Hemels, ME; Hudry, J	1
Addington, S; Dichter, GS; Freid, CM; Shelton, RC; Tomarken, AJ	1
Hauser, P; Hisley, KC; Lefkowitz, DM; Marano, C; Obuchowski, A; Regenold, WT	1
Almási, J; Rihmer, Z	1
Kennedy, SH; Lam, RW	1
Benazzi, F	1
Berger, M; Feige, B; Nissen, C; Nofzinger, E; Riemann, D; Voderholzer, U	1
Bastiaens, L	1
Entsuah, R; Padmanabhan, SK; Shelton, C; Vinall, PE	1
Posternak, MA; Zimmerman, M	1
Bannan, N	1
Devarajan, S; Dursun, SM	1
Einarson, TR; van Baardewijk, M; Vis, PM	2
Briley, M; Grady, MM; Moret, C; Stahl, SM	1
Cantillon, M; Entsuah, R; Kornstein, SG; Thase, ME	1
Burt, T; D'Souza, RF; George, T; Hopwood, M; Lam, W; Martin, AJ; Sir, A; Uguz, S; Vahip, S	1
Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM	1
Brørs, O; Melien, Ø; Myhr, K; Skaali, T	1
Baldwin, DS; Lader, M; Montgomery, SA; Nil, R	1
Giordani, S; Lucca, A; Magri, L; Rossini, D; Smeraldi, E; Zanardi, R	1
Baker, RA; Benkert, O; Heinrich, C; Heukels, A; Kohnen, R; Philipp, M; Schutte, AJ; Simmons, JH; Szegedi, A; van der Vegte-Senden, M	1
Ballon, JS; Schulman, MC	1
Benattia, I; Graepel, J; Kroenke, K; Messina, N; Musgnung, J	1
Liau, CH; Shen, WW; Su, KP	1
Al-Adwani, A	1
Millan, MJ	1
Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Andersen, HF; Kennedy, SH; Lam, RW	1
Roose, S; Schatzberg, A	1
Begley, AE; Kirshne, MA; Mulsant, BH; Pollock, BG; Reynolds, CF; Romkes, M; Whyte, EM	1
Sicot, R	1
Keltner, NL; Lee, SI	1
Blier, P; de Montigny, C; Debonnel, G; Hébert, C; Lavoie, N; Saint-André, E	1
Khan, A; Shelton, RC; Thase, ME	1
Briggs, SD; Case, M; Corya, SA; Sanger, TM; Tollefson, G; Williamson, D	1
Hsiao, CC	1
Anghelescu, I; Luborzewski, A; Regen, F; Schindler, F	1
Kim, YK; Lee, KM	1
Akgoz, S; Akkaya, C; Kirli, S; Sarandol, A; Saygin Eker, S; Yazicioglu, B	1
Akgoz, S; Akkaya, C; Eker, SS; Kirli, S; Sivrioglu, EY	1
Eckert, L; Lançon, C	1
Cook, IA; Hunter, AM; Leuchter, AF; Morgan, ML	1
Andersen, HF; Montgomery, SA	1
Abad-Santos, F; Adan-Manes, J; Ayuso-Mateos, JL; López-Rodríguez, R; Novalbos, J	1
Begley, AE; Johnson, EM; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E; Whyte, E	1
Valenstein, M	1
Biggs, MM; Davis, L; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Clayton, AH; Haight, BR; Johnston, JA; Modell, JG; Thase, ME; Thompson, AH	1
Fotiou, F; Fountoulakis, KN; Gerasimou, G; Grammatikos, P; Iacovides, A; Kaprinis, G; Karamouzis, M	1
Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I	1
Eckert, L; Falissard, B	1
Kornstein, SG	1
Gendron, A; McIntyre, A	1
Bremner, JD; Charney, DS; Vermetten, E; Vythilingam, M	1
Dunner, DL; Haman, KL; Hirschfeld, RM; Kiev, A; Lydiard, RB; Rapaport, MH; Shelton, RC; Smith, WT; Zajecka, JM	1
Berman, SA; Packer, S	1
Barbui, C; Cipriani, A; Geddes, JR	1
Artiges, E; Bragulat, V; Frouin, V; Martinot, JL; Paillère-Martinot, ML; Poline, JB	1
Emslie, GJ; Kunz, NR; Yeung, PP	1
de Leeuw, FE; Heeren, TJ; Hulshoff Pol, HE; Janssen, J; Kahn, RS; Kok, RM; Lampe, IK; Schnack, HG	1
Archambaud, F; Buhl, C; Chouinard, G; Corruble, E; Hardy, P; Prigent, A; Schuster, JP	1
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R	1
Fernandez, JL; Llorca, PM	1
Alam, F; Ashim, S; Bennett, D; Mbaya, P	1
Emslie, GJ; Findling, RL; Kunz, NR; Li, Y; Yeung, PP	1
Carandang, C; Carrey, N; Gardner, DM; Kutcher, S; Santor, D	1
Bauer, M; Froud, DM; Jain, R; Kajdasz, DK; Perahia, DG; Pritchett, YL; Raskin, J; Russell, JM; Spencer, KA; Thase, ME; Walker, DJ	1
Damsbo, N; Hemels, ME; Le Lay, A; Stage, KB; Sørensen, J	1
Connor, K; Davidson, JR; Vaishnavi, S	1
Biggs, MM; Fava, M; Friedman, ES; Hollon, SD; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Dierkes, W; Linden, M; Munz, T	1
Alves Valle, E; Araújo Silva, S; Avila de Melo, R; da Costa Júnior, AL; de Souza Neto, JJ; de Vasconcelos Cunha, UG; Faria Alves, VX; Lopes Rocha, F; Magalhães Scoralick, F; Martins de Oliveira, F; Mendes Brega, R; Sakurai, E	1
Boovariwala, A; Ginovart, N; Houle, S; Meyer, JH; Rusjan, P; Sagrati, S; Sokolov, S; Spencer, EP; Voineskos, AN; Wilson, AA	1
DeMartinis, NA; Entsuah, R; Manley, AL; Yeung, PP	1
Aharonovich, E; Bisaga, A; Brooks, DJ; Garawi, F; Levin, FR; Mariani, J; Nunes, EV; Raby, W; Rubin, E	1
Chen, YC; Lu, RB; Wu, YS	1
Berlim, MT; Turecki, MG	1
Barbuzza, O; Borgia, F; Guarneri, B; Vaccaro, M	1
Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM	1
Black, JL; McAlpine, DE; Mrazek, DA; O'Kane, DJ	1
Heeren, TJ; Kok, RM; Nolen, WA; Vink, D	1
Gillman, K	1
Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME	1
Hsiao, MC; Liu, CY	1
Germain, JM; Padmanabhan, SK; Pitrosky, B; Septien-Velez, L; Tourian, KA	1
Fava, M; Papakostas, GI; Thase, ME	1
Jagadheesan, K; Lusicic, A	1
Entsuah, R; Liebowitz, MR; Yeung, PP	1
Alvarez, E; Guilleminault, C; Lemoine, P	1
Byrd, EH; Chismar, R; Dey, S; Holtzheimer, PE; Kelley, ME; McDonald, WM; McWhorter, K; Meeks, TW; Mufti, M; Quinn, S; Vito, N; Young, R	1
Alpert, JE; Balasubramani, GK; Biggs, MM; Carmin, CN; Fava, M; Howland, R; Leuchter, A; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S	1
Alexandrino-Silva, C; de Andrade, AG; de Toledo Ferraz Alves, TC; Nadalini Mauá, FH	1
Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A; Sarandol, E	1
Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS	1
Abebe, K; Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Hughes, C; Iyengar, S; Keller, M; Kennard, B; Leonard, H; McCracken, J; Melhem, N; Onorato, M; Porta, G; Ritz, L; Ryan, N; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD; Zelazny, J	1
Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH	1
Case, K; Cramer-Bornemann, M; Hurwitz, TD; Kim, SW; Schenck, CH	1
Cox, SK; Reeves, RR	1
Lyons, JE; Symon, J	1
Bria, P; Camardese, G; Picello, A	1
Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Kozeny, J; Krajca, V; Novak, T; Sos, P; Stopkova, P	1
Fulton, K; Kennedy, SH; Rasmussen, J; Rizvi, S	1
Amsterdam, JD; Shults, J; Shwarz, M; Wang, CH	1
Freemantle, N	1
Brilmyer, M; Kant, R; Zeiler, D; Zimmer, B	1
Rajagopalan, M	1
Spier, SA	1
Kubb, R; Lyndon, B; Walter, G	1
Chouinard, G; Dallal, A	1
Amsterdam, J	1
Arikian, SR; Casciano, J; Doyle, JJ; Einarson, TR	1
Corruble, E; Guelfi, JD	1
Peretti, CS	1
Poirier, MF	1
Reznik, I; Rosen, B; Rosen, Y	1
Brager, N; Tham, CJ; Trew, M	1
Blauer, F; Fleisch, MC; Gubler, JG; Kuhn, M; Scherer, TA	1
Blanco, C; Mullen, LS; Roose, SP; Vaughan, R; Vaughan, SC	1
Levin, FR; McDowell, DM; Nunes, EV; Seracini, AM	1
Benedictis, E; D'Arrigo Busnello, E; De Campos, JA; De Cassia Rodrigues, RL; Gentil, V; Juruena, MF; Kerr-Correa, F; Lafer, B; Moreno, DH; Moreno, R; Tiosso, A	1
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD	1
Amsterdam, JD; Garcia-España, F	1
Golden, RN; Nicholas, L	1
Kienke, AS; Rosenbaum, JF	1
Friedman, ES; Howland, RH; Thase, ME	1
Evans, DL; Staab, JP	1
Ninan, PT	1
Behar, D; Schaller, JL	1
Burrows, G; Flynn, P; George, T; Mitchell, P; Polonowita, A; Schweitzer, I; Theodoros, M; Tuckwell, V	1
Baumann, P; Preisig, M; Zullino, D	1
Cook, IA; Leuchter, AF	1
Arikian, S; Casciano, J; Casciano, R; Doyle, J	1
Ishigooka, J	1
Perry, CM; Wellington, K	1
Cheng, CY; Hong, CJ; Huo, SJ; Tsai, SJ; Wu, WH	1
Abrams, M; Cook, IA; Leuchter, AF; Morgan, M; Witte, EA	1
Entsuah, AR; Huang, H; Thase, ME	1
Bagby, RM; Kennedy, SH; Vanderkooy, JD	1
Elizagarate, E; Gonzalez, N; Gonzalez-Pinto, A; Gutierrez, M; Mico, JA; Perez de Heredia, JL	1
Amsterdam, JD; Hornig-Rohan, M	1
Abrams, M; Cook, IA; Leuchter, AF; Morgan, M; Rosenberg, S; Stubbeman, WF; Uijtdehaage, SH; Witte, E	1

Reviews

75 review(s) available for cyclohexanol and Depression, Involutional

Article	Year
Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine. Psychopharmacology, 2022, Volume: 239, Issue:9 Topics: Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	2022
Desvenlafaxine in the treatment of major depression: an updated overview. Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:9 Topics: Adolescent; Adult; Antidepressive Agents; Child; Cyclohexanols; Depression; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Interactions; Female; Humans	2021
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder. Journal of affective disorders, 2013, Sep-05, Volume: 150, Issue:2 Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2013
Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:1 Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2014
Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine. Drug design, development and therapy, 2013, Volume: 7 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride	2013
Early improvement in depressive symptoms with desvenlafaxine 50 mg/d as a predictor of treatment success in patients with major depressive disorder. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult	2014
Desvenlafaxine for the treatment of major depressive disorder. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Interactions; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors	2014
The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies. Human psychopharmacology, 2014, Volume: 29, Issue:5 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Randomized Controlled Trials as Topic	2014
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies. Current medical research and opinion, 2014, Volume: 30, Issue:12 Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine	2014
Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis. Current medical research and opinion, 2015, Volume: 31, Issue:4 Topics: Adult; Antidepressive Agents; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2015
[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue]. L'Encephale, 2008, Volume: 34, Issue:1 Topics: Affect; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Mianserin; Mirtazapine; Patient Satisfaction; Personality Inventory; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Suicide Prevention; Thiophenes; Time Factors; Treatment Refusal; Venlafaxine Hydrochloride	2008
A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. International clinical psychopharmacology, 2008, Volume: 23, Issue:4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2008
Desvenlafaxine succinate for the treatment of major depressive disorder. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:12 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Selective Serotonin Reuptake Inhibitors	2008
New antidepressants for older people: a critical review of the evidence base. L'Encephale, 2008, Volume: 34 Suppl 2 Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Fluoxetine; Humans; Patient Care Team; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Desvenlafaxine: another "me too" drug? The Annals of pharmacotherapy, 2008, Volume: 42, Issue:10 Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Costs; Drug Interactions; Humans; Remission Induction; Venlafaxine Hydrochloride	2008
Desvenlafaxine succinate for major depressive disorder. Drugs of today (Barcelona, Spain : 1998), 2008, Volume: 44, Issue:7 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Selective Serotonin Reuptake Inhibitors	2008
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. The American journal of psychiatry, 2008, Volume: 165, Issue:10 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride	2008
Desvenlafaxine extended release. CNS drugs, 2008, Volume: 22, Issue:12 Topics: Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Administration Schedule; Humans; Neurotransmitter Uptake Inhibitors	2008
Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system. Journal of psychiatric practice, 2008, Volume: 14, Issue:6 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desipramine; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Health Status; Humans; Paroxetine; Thiophenes	2008
Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence. Expert review of neurotherapeutics, 2008, Volume: 8, Issue:12 Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans	2008
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. European archives of psychiatry and clinical neuroscience, 2009, Volume: 259, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Humans; Middle Aged; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2009
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity. European archives of psychiatry and clinical neuroscience, 2009, Volume: 259, Issue:6 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Reference Values; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Venlafaxine Hydrochloride	2009
Desvenlafaxine: a new antidepressant or just another one? Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:5 Topics: Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Nausea; Randomized Controlled Trials as Topic	2009
[Severe forms of depression: the efficacy of escitalopram]. L'Encephale, 2009, Volume: 35, Issue:2 Topics: Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Paroxetine; Personality Inventory; Psychometrics; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2009
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder. CNS spectrums, 2009, Volume: 14, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2009
Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials. CNS spectrums, 2009, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Time Factors; Venlafaxine Hydrochloride; Young Adult	2009
Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder. Clinical therapeutics, 2009, Volume: 31 Pt 1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Area Under Curve; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Half-Life; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Pregnancy	2009
Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:10 Topics: Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Status; Humans; Male; Placebos; Psychometrics; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Treatment Outcome	2009
Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician. Current medical research and opinion, 2010, Volume: 26, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Humans; Neurotransmitter Uptake Inhibitors; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome	2010
[Cholinesterase inhibitors and depression in the elderly]. L'Encephale, 2010, Volume: 36, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cholinesterase Inhibitors; Cognition Disorders; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Neuropsychological Tests; Venlafaxine Hydrochloride	2010
Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis. International clinical psychopharmacology, 2010, Volume: 25, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2010
Analysis of the effect of desvenlafaxine on anxiety symptoms associated with major depressive disorder: pooled data from 9 short-term, double-blind, placebo-controlled trials. CNS spectrums, 2010, Volume: 15, Issue:3 Topics: Adult; Antidepressive Agents; Anxiety; Clinical Trials, Phase III as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients. Drugs & aging, 2010, Aug-01, Volume: 27, Issue:8 Topics: Aged; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Interactions; Duloxetine Hydrochloride; Humans; Thiophenes	2010
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Acta psychiatrica Scandinavica, 2011, Volume: 123, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Duloxetine Hydrochloride; Humans; Pharmacological Phenomena; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2011
Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor. Expert opinion on drug metabolism & toxicology, 2010, Volume: 6, Issue:12 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclohexanols; Cytochrome P-450 Enzyme System; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors	2010
Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis. International clinical psychopharmacology, 2012, Volume: 27, Issue:1 Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Disability Evaluation; Emotions; Evidence-Based Medicine; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Psychiatric Status Rating Scales; Recovery of Function; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome	2012
Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies. International clinical psychopharmacology, 2012, Volume: 27, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Evidence-Based Medicine; Female; Humans; Male; Odds Ratio; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2012
Desvenlafaxine in the treatment of major depressive disorder. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:18 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of general psychiatry, 2012, Volume: 69, Issue:6 Topics: Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide; Venlafaxine Hydrochloride	2012
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Archives of general psychiatry, 2012, Volume: 69, Issue:6 Topics: Adolescent; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depression and anxiety, 2002, Volume: 16, Issue:1 Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2002
Optimizing treatment outcomes for patients with depression and generalized anxiety disorder. Psychopharmacology bulletin, 2002,Summer, Volume: 36 Suppl 2 Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Humans; Paroxetine; Psychotherapy; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Mechanism of action of antidepressants. Psychopharmacology bulletin, 2002,Summer, Volume: 36 Suppl 2 Topics: Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2002
A pharmacoeconomic evaluation of major depressive disorder. Managed care interface, 2003, Volume: Suppl B Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Critical Pathways; Cyclohexanols; Decision Trees; Depressive Disorder, Major; Economics, Pharmaceutical; Humans; Venlafaxine Hydrochloride	2003
Dual action antidepressants and some important considerations. The Australian and New Zealand journal of psychiatry, 2003, Volume: 37, Issue:2 Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Histamine H1 Antagonists; Humans; Mianserin; Milnacipran; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride; Weight Gain	2003
Treatment of pain syndromes with venlafaxine. Pharmacotherapy, 2004, Volume: 24, Issue:5 Topics: Analgesics; Animals; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Humans; Pain; Pain, Postoperative; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2004
Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:8 Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
SNRIs in the management of acute major depressive disorder. The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 17 Topics: Acute Disease; Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Placebos; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2004
Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful? The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 17 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Humans; Long-Term Care; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. International clinical psychopharmacology, 2005, Volume: 20, Issue:2 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Outpatients; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Refusal; Venlafaxine Hydrochloride	2005
[Review of antidepressants from the TCAs to the third generation drugs]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2004, Volume: 6, Issue:4 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride	2004
Using metaanalysis to evaluate evidence: practical tips and traps. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride	2005
Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder. Current medical research and opinion, 2005, Volume: 21, Issue:8 Topics: Adolescent; Adult; Cost of Illness; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Depressive Disorder, Major; Duloxetine Hydrochloride; Economics, Pharmaceutical; Health Care Costs; Humans; Middle Aged; Models, Econometric; Norepinephrine; Ontario; Outpatients; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2005
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS spectrums, 2005, Volume: 10, Issue:9 Topics: Antidepressive Agents; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; In Vitro Techniques; Milnacipran; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Vesicular Monoamine Transport Proteins	2005
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:11 Topics: Adult; Cyclohexanols; Data Collection; Delayed-Action Preparations; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Patient Dropouts; Randomized Controlled Trials as Topic; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2005
Discontinuation symptoms in depression and anxiety disorders. The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Withholding Treatment	2007
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacology & therapeutics, 2006, Volume: 110, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dopamine; Dopamine Uptake Inhibitors; Drug Delivery Systems; Drug Design; Drug Therapy, Combination; Humans; Morpholines; Nerve Net; Neurons; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	2006
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. Journal of psychiatry & neuroscience : JPN, 2006, Volume: 31, Issue:2 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2006
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons. BMC psychiatry, 2006, Jul-24, Volume: 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Regression Analysis; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2006
Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation. International journal of clinical practice, 2007, Volume: 61, Issue:4 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Humans; Meta-Analysis as Topic; Models, Econometric; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2007
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biological psychiatry, 2008, Feb-15, Volume: 63, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2008
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biological psychiatry, 2008, Apr-01, Volume: 63, Issue:7 Topics: Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis. Psychopharmacology, 2008, Volume: 196, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Patient Dropouts; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials. Clinical therapeutics, 1999, Volume: 21, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
[Is there a relationship between clinical efficacy and antidepressant dosage in major depression?]. L'Encephale, 1999, Volume: 25 Spec No 2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Imipramine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
[Therapeutic action lag time and resistance to treatment]. L'Encephale, 1999, Volume: 25 Spec No 2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dibenzocycloheptenes; Drug Resistance; Fluoxetine; Hospitalization; Humans; Severity of Illness Index; Time Factors; Venlafaxine Hydrochloride	1999
Antidepressant efficacy of venlafaxine. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Humans; Treatment Outcome; Venlafaxine Hydrochloride	2000
Efficacy of venlafaxine in the treatment of severe depression. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2000
Venlafaxine and treatment-resistant depression. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Efficacy of venlafaxine in geriatric depression. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Aged; Cyclohexanols; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2000
Use of venlafaxine in other psychiatric disorders. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride	2000
The health economic impact of antidepressant usage from a payer's perspective: a multinational study. International journal of clinical practice, 2001, Volume: 55, Issue:5 Topics: Acute Disease; Algorithms; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Costs; Europe; Health Care Costs; Health Policy; Humans; North America; Venlafaxine Hydrochloride	2001
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:8 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Venlafaxine extended-release: a review of its use in the management of major depression. CNS drugs, 2001, Volume: 15, Issue:8 Topics: Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:11 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001

Trials

219 trial(s) available for cyclohexanol and Depression, Involutional

Article	Year
A randomized controlled trial of desvenlafaxine-induced structural brain changes in the treatment of persistent depressive disorder. Psychiatry research. Neuroimaging, 2023, Volume: 331 Topics: Brain; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Humans	2023
Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis. Journal of psychiatric research, 2020, Volume: 129 Topics: Antidepressive Agents; Cluster Analysis; Cyclohexanols; Data Analysis; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2020
Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study. BMC psychiatry, 2021, 05-19, Volume: 21, Issue:1 Topics: Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Postmenopause; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2021
Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:2 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2013
A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder. BMC psychiatry, 2013, Mar-22, Volume: 13 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome	2013
Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study. The Journal of nervous and mental disease, 2013, Volume: 201, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Psychometrics; Secondary Prevention; Sexual Dysfunction, Physiological; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult	2013
Dynamic prediction of treatment response in late-life depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:2 Topics: Age of Onset; Aged; Aged, 80 and over; Aripiprazole; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Remission Induction; Severity of Illness Index; Signal Detection, Psychological; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride	2014
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. Journal of affective disorders, 2013, Sep-25, Volume: 150, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Remission Induction; Risperidone; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder. International clinical psychopharmacology, 2013, Volume: 28, Issue:4 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Drug Monitoring; Female; Headache; Humans; Incidence; Intention to Treat Analysis; Japan; Male; Middle Aged; Nasopharyngitis; Nausea; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales	2013
The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients. Journal of affective disorders, 2013, Sep-05, Volume: 150, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Risk; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult	2013
Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder. Psychiatry research, 2013, Aug-15, Volume: 208, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Catechol O-Methyltransferase; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Genotype; Humans; Male; Methionine; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Time Factors; Valine; Venlafaxine Hydrochloride; Young Adult	2013
A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients. Journal of psychiatric research, 2013, Volume: 47, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Inpatients; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2013
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial. Trials, 2013, Jul-18, Volume: 14 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; California; Citalopram; Clinical Protocols; Cognition; Cyclohexanols; Depressive Disorder, Major; Diffusion Tensor Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; New South Wales; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies. International clinical psychopharmacology, 2013, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebo Effect; Severity of Illness Index; Young Adult	2013
Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Medical hypotheses, 2013, Volume: 81, Issue:6 Topics: Affect; Antidepressive Agents; Conditioning, Classical; Cyclohexanols; Depressive Disorder, Major; Drug Tolerance; Electroencephalography; Female; Humans; Learning; Models, Biological; Statistics, Nonparametric; Substance-Related Disorders; Venlafaxine Hydrochloride	2013
Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months. JAMA psychiatry, 2013, Volume: 70, Issue:11 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Depressive Disorder, Major; Double-Blind Method; Emotions; Fluoxetine; Functional Neuroimaging; Humans; Prefrontal Cortex; Venlafaxine Hydrochloride	2013
Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10 Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Humans; Menopause; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome	2013
How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine. CNS spectrums, 2015, Volume: 20, Issue:1 Topics: Acetamides; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Venlafaxine Hydrochloride	2015
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:1 Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Menopause; Middle Aged; Placebos; Proportional Hazards Models; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Venlafaxine Hydrochloride	2014
Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:8 Topics: Administration, Oral; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Menopause; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome	2014
Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine. International clinical psychopharmacology, 2014, Volume: 29, Issue:5 Topics: Adult; Aged; Antidepressive Agents; Canada; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Efficiency; Employment; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales; Self Report; Severity of Illness Index; Time Factors; United States; Young Adult	2014
Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder. Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:4 Topics: Adolescent; Antidepressive Agents; Child; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Male; Severity of Illness Index; Suicidal Ideation; Time Factors	2014
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care. Journal of psychiatric practice, 2014, Volume: 20, Issue:2 Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride	2014
QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder. Clinical EEG and neuroscience, 2015, Volume: 46, Issue:2 Topics: Algorithms; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Computer-Assisted; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Reproducibility of Results; Sensitivity and Specificity; Theta Rhythm; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride	2015
Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d. Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:3 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Administration Schedule; Humans; Outpatients; Substance Withdrawal Syndrome	2014
Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder. Journal of affective disorders, 2014, Volume: 166 Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Employment; Female; Humans; Male; Middle Aged; Placebos; Quality of Life; Surveys and Questionnaires; Young Adult	2014
Venlafaxine, paroxetine and milnacipran for major depressive disorder: a pragmatic 24-week study. The Chinese journal of physiology, 2014, Oct-31, Volume: 57, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2014
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome. Pharmacopsychiatry, 2014, Volume: 47, Issue:7 Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride; Young Adult	2014
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. The British journal of psychiatry : the journal of mental science, 2015, Volume: 206, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline; Remission Induction; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2015
Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients. Psychopharmacology, 2015, Volume: 232, Issue:8 Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2015
Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:5 Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Sexual Dysfunction, Physiological; Treatment Outcome	2015
Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients. Pharmacopsychiatry, 2015, Volume: 48, Issue:1 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Platelet Count; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2015
Differences in quality of life outcomes among depressed spinal cord injury trial participants. Archives of physical medicine and rehabilitation, 2015, Volume: 96, Issue:2 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Health Status; Humans; Male; Mental Health; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Spinal Cord Injuries; Venlafaxine Hydrochloride; Young Adult	2015
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride	2015
Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial. Archives of physical medicine and rehabilitation, 2015, Volume: 96, Issue:4 Topics: Adolescent; Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Medication Adherence; Middle Aged; Neuralgia; Nociceptive Pain; Pain; Psychiatric Status Rating Scales; Spinal Cord Injuries; Trauma Severity Indices; Venlafaxine Hydrochloride; Young Adult	2015
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial. JAMA psychiatry, 2015, Volume: 72, Issue:3 Topics: Adolescent; Adult; Chronic Disease; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Spinal Cord Injuries; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study. Current medical research and opinion, 2015, Volume: 31, Issue:4 Topics: Adolescent; Adult; Aged; Anxiety; Asia; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sulfides; Venlafaxine Hydrochloride; Vortioxetine; Young Adult	2015
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial. The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Remission Induction; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2015
Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phototherapy; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2015
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Outpatients; Placebos; Treatment Outcome	2008
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of psychiatric research, 2009, Volume: 43, Issue:3 Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cyclohexanols; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2009
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Half-Life; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Suicide; Venlafaxine Hydrochloride	2008
Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Archives of general psychiatry, 2008, Volume: 65, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chlorates; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Venlafaxine Hydrochloride	2009
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of general psychiatry, 2008, Volume: 65, Issue:8 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride	2008
Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology, 2008, Volume: 57, Issue:4 Topics: Adult; Antidepressive Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Case-Control Studies; Chi-Square Distribution; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Matched-Pair Analysis; Neuropsychological Tests; Paroxetine; Reference Values; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2008
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? Journal of affective disorders, 2009, Volume: 115, Issue:1-2 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Personality Inventory; Psychometrics; Retreatment; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial. International clinical psychopharmacology, 2008, Volume: 23, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2008
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult	2010
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study. International clinical psychopharmacology, 2008, Volume: 23, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Recurrence; Risk Assessment; Time Factors; Treatment Failure; Venlafaxine Hydrochloride	2008
Outcome of late-life depression after 3 years of sequential treatment. Acta psychiatrica Scandinavica, 2009, Volume: 119, Issue:4 Topics: Age of Onset; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Nortriptyline; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2009
Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta psychiatrica Scandinavica, 2009, Volume: 119, Issue:4 Topics: Brain; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2009
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting. Human psychopharmacology, 2009, Volume: 24, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain	2009
A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder. CNS spectrums, 2009, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Outpatients; Placebos; Treatment Outcome; Young Adult	2009
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:2 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Feasibility Studies; Female; Humans; Male; Personality Inventory; Pilot Projects; Piperazines; Quinolones; Thiophenes; Venlafaxine Hydrochloride	2009
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. The American journal of psychiatry, 2009, Volume: 166, Issue:4 Topics: Adolescent; Antidepressive Agents; Benzodiazepines; Citalopram; Cognitive Behavioral Therapy; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide; Suicide, Attempted; Venlafaxine Hydrochloride	2009
Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features. International clinical psychopharmacology, 2009, Volume: 24, Issue:2 Topics: Adult; Antidepressive Agents; Blood Pressure; Constipation; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Double-Blind Method; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Venlafaxine Hydrochloride; Xerostomia	2009
Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. Journal of affective disorders, 2009, Volume: 118, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Assessment; Prefrontal Cortex; Psychometrics; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride	2009
Early response as predictor of final remission in elderly depressed patients. International journal of geriatric psychiatry, 2009, Volume: 24, Issue:11 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Humans; Middle Aged; Nortriptyline; Remission Induction; ROC Curve; Treatment Outcome; Venlafaxine Hydrochloride	2009
Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression. Psychotherapy research : journal of the Society for Psychotherapy Research, 2009, Volume: 19, Issue:2 Topics: Adolescent; Adult; Aged; Algorithms; Choice Behavior; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Interview, Psychological; Male; Middle Aged; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants. The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:1 Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; G-Protein-Coupled Receptor Kinase 2; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Male; Middle Aged; RNA, Messenger; Treatment Outcome; Venlafaxine Hydrochloride	2010
An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder. CNS spectrums, 2009, Volume: 14, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Liver Function Tests; Male; Middle Aged; Suicide; Venlafaxine Hydrochloride; Young Adult	2009
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of psychiatry & neuroscience : JPN, 2009, Volume: 34, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Venlafaxine Hydrochloride; Young Adult	2009
A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data. Statistics in medicine, 2009, Aug-15, Volume: 28, Issue:18 Topics: Antidepressive Agents, Second-Generation; Biometry; Computer Simulation; Cyclohexanols; Depressive Disorder, Major; Humans; Linear Models; Lithium Compounds; Longitudinal Studies; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Venlafaxine Hydrochloride	2009
Frontal EEG predictors of treatment outcome in major depressive disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:11 Topics: Adolescent; Adult; Cyclohexanols; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Humans; Male; Middle Aged; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Archives of general psychiatry, 2009, Volume: 66, Issue:7 Topics: Adult; Aged; Antidepressive Agents; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	2009
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. Journal of psychiatric research, 2010, Volume: 44, Issue:2 Topics: Antidepressive Agents; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Numerical Analysis, Computer-Assisted; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	2010
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies. Journal of affective disorders, 2010, Volume: 120, Issue:1-3 Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride	2010
Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial. Psychiatry research, 2009, Sep-30, Volume: 169, Issue:2 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Somatosensory Disorders; Venlafaxine Hydrochloride	2009
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Clinical therapeutics, 2009, Volume: 31 Pt 1 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Neurotransmitter Uptake Inhibitors; Placebos	2009
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study. Psychopharmacology bulletin, 2009, Volume: 42, Issue:3 Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride	2009
Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Feb-01, Volume: 34, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antigens, CD; Cyclohexanols; Depressive Disorder, Major; Female; Flow Cytometry; Fluoxetine; Humans; Lymphocyte Subsets; Male; Statistics, Nonparametric; Venlafaxine Hydrochloride; Young Adult	2010
Substance use and the treatment of resistant depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:12 Topics: Adolescent; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit and Disruptive Behavior Disorders; Child Abuse; Child Abuse, Sexual; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Conduct Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Resistance; Drug Therapy, Combination; Family Conflict; Female; Humans; Illicit Drugs; Male; Personality Inventory; Psychometrics; Psychotropic Drugs; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride	2009
Long-term response to successful acute pharmacological treatment of psychotic depression. Journal of affective disorders, 2010, Volume: 123, Issue:1-3 Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Netherlands; Quetiapine Fumarate; Treatment Outcome; Venlafaxine Hydrochloride	2010
What did STARD teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adolescent; Adult; Aged; Bupropion; Citalopram; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Primidone; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Pharmacogenetics studies in STARD: strengths, limitations, and results. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2009
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:8 Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2010
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR. International clinical psychopharmacology, 2010, Volume: 25, Issue:1 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged; Nausea; Treatment Outcome; Venlafaxine Hydrochloride	2010
[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study]. L'Encephale, 2009, Volume: 35, Issue:6 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; France; Humans; Male; Middle Aged; Milnacipran; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Venlafaxine Hydrochloride; Young Adult	2009
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. The American journal of psychiatry, 2010, Volume: 167, Issue:3 Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride	2010
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trial. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome	2010
Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients. Psychotherapy and psychosomatics, 2010, Volume: 79, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Retinol-Binding Proteins, Plasma; Venlafaxine Hydrochloride	2010
Correlation between patient and clinician assessments of depression severity in the PREVENT study. Psychiatry research, 2010, May-15, Volume: 177, Issue:1-2 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics as Topic; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2010
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. Psychiatry research, 2010, May-15, Volume: 177, Issue:1-2 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Circadian Rhythm; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Saliva; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2010
Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:6 Topics: Adult; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain; California; Causality; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Mood Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Suicide; Venlafaxine Hydrochloride	2010
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. Journal of affective disorders, 2010, Volume: 126, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Long-Term Care; Longitudinal Studies; Male; Middle Aged; Quality of Life; Secondary Prevention; Social Adjustment; Surveys and Questionnaires; Venlafaxine Hydrochloride	2010
Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4 Topics: Adult; Aged; Blood Pressure; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Liver Function Tests; Middle Aged; Neurotransmitter Uptake Inhibitors; Postmenopause; Selective Serotonin Reuptake Inhibitors; Sleep; Weight Gain	2010
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride	2010
Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder. Journal of affective disorders, 2010, Volume: 126, Issue:3 Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Neuropsychological Tests; Pharmacogenetics; Polymorphism, Single Nucleotide; Taiwan; Venlafaxine Hydrochloride	2010
Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:8 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Menopause; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome	2010
Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder. Psychiatria Danubina, 2010, Volume: 22, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Personality Inventory; Psychometrics; Slovenia; Venlafaxine Hydrochloride; Young Adult	2010
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia; Brain; Cyclohexanols; Depressive Disorder, Major; Emotions; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Prefrontal Cortex; Psychiatric Status Rating Scales; Time Factors; Venlafaxine Hydrochloride	2011
TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology, 2011, Volume: 213, Issue:4 Topics: Adult; Asian People; Case-Control Studies; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Taiwan; Treatment Outcome; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult	2011
Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder. Psychopharmacology bulletin, 2010, Volume: 43, Issue:2 Topics: Adult; Ambulatory Care; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Patient Education as Topic; Patient Satisfaction; Primary Health Care; Program Evaluation; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Support; Surveys and Questionnaires; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride	2010
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	2010
Neural correlates of treatment outcome in major depression. The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:4 Topics: Adult; Affect; Antidepressive Agents; Biomarkers; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Face; Female; Frontal Lobe; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Net; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks. The journal of ECT, 2011, Volume: 27, Issue:2 Topics: Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Quality of Life; Time Factors; Venlafaxine Hydrochloride	2011
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials, 2011, Jan-05, Volume: 12 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cognition; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Electroencephalography; Emotions; Europe; Female; Humans; Male; Middle Aged; Neuropsychological Tests; New Zealand; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Behavior; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult	2011
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:3 Topics: Activities of Daily Living; Adolescent; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Suicidal Ideation; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2011
Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prospective Studies; Triglycerides; Venlafaxine Hydrochloride	2011
Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram. CNS drugs, 2011, Volume: 25, Issue:3 Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Resistance; Female; Humans; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome	2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Archives of general psychiatry, 2011, Volume: 68, Issue:3 Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2011
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors. Current medical research and opinion, 2011, Volume: 27, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Norepinephrine; Remission Induction; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:5 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Monitoring; Drug Resistance; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride	2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. The American journal of psychiatry, 2011, Volume: 168, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Personality Inventory; Recurrence; Selective Serotonin Reuptake Inhibitors; Self Report; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry research, 2011, Jun-30, Volume: 192, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Follow-Up Studies; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Theta Rhythm; Venlafaxine Hydrochloride	2011
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine	2012
Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and responders. Current medical research and opinion, 2011, Volume: 27, Issue:9 Topics: Adolescent; Adult; Aged; Algorithms; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Resistance; Drug Substitution; Female; Humans; Male; Middle Aged; Placebos; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder. Biological psychiatry, 2011, Nov-15, Volume: 70, Issue:10 Topics: Adult; Anhedonia; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Emotions; Female; Fluoxetine; Follow-Up Studies; Functional Laterality; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Prefrontal Cortex; Psychiatric Status Rating Scales; Pupil; Surveys and Questionnaires; Venlafaxine Hydrochloride; Young Adult	2011
Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5 Topics: Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Employment; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2011
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:5 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Placebos; Tropanes; Venlafaxine Hydrochloride	2012
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:10 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Ethnicity; Female; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychotherapy, Brief; Sertraline; Sex Characteristics; Venlafaxine Hydrochloride	2012
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STARD. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1* Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult	2012
Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:1 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Migraine Disorders; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Venlafaxine Hydrochloride	2012
Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:1 Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Labeling; Drug Resistance; Humans; Patient Selection; Selective Serotonin Reuptake Inhibitors; Suicide Prevention; Venlafaxine Hydrochloride	2012
Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:1 Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sleep Wake Disorders; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride	2012
Does prior antidepressant treatment of major depression impact brain function during current treatment? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012, Volume: 22, Issue:10 Topics: Adult; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Los Angeles; Male; Middle Aged; Neurons; Prefrontal Cortex; Psychiatric Status Rating Scales; Self Report; Single-Blind Method; Theta Rhythm; Venlafaxine Hydrochloride	2012
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. Journal of the American Academy of Child and Adolescent Psychiatry, 2012, Volume: 51, Issue:4 Topics: Adolescent; Affect; Anhedonia; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Resistance; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Personality Assessment; Psychometrics; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression. Nordic journal of psychiatry, 2012, Volume: 66, Issue:3 Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2012
Recovery and subsequent recurrence in patients with recurrent major depressive disorder. Journal of psychiatric research, 2012, Volume: 46, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Psychiatric Status Rating Scales; Recovery of Function; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2012
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depression and anxiety, 2012, Volume: 29, Issue:2 Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study. Psychoneuroendocrinology, 2013, Volume: 38, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Asian People; Cyclohexanols; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Suicidal Ideation; Tumor Necrosis Factor-alpha; Up-Regulation; Venlafaxine Hydrochloride; Young Adult	2013
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Oct-01, Volume: 39, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Autonomic Nervous System; Case-Control Studies; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Entropy; Female; Heart Rate; Humans; Recurrence; Respiratory Rate; Venlafaxine Hydrochloride	2012
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:4 Topics: Acetamides; Adolescent; Adult; Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Patient Dropouts; Pilot Projects; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2012
Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Norepinephrine; Venlafaxine Hydrochloride	2012
High-dose desvenlafaxine in outpatients with major depressive disorder. CNS spectrums, 2012, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Longitudinal Studies; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2012
An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo. The journal of sexual medicine, 2013, Volume: 10, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Prospective Studies; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Surveys and Questionnaires	2013
Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment. Pharmacopsychiatry, 2013, Volume: 46, Issue:2 Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Venlafaxine Hydrochloride	2013
Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. The American journal of psychiatry, 2013, Volume: 170, Issue:2 Topics: Affect; Antidepressive Agents; Biological Availability; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Nucleus Accumbens; Psychiatric Status Rating Scales; Reward; Sickness Impact Profile; Treatment Outcome; Venlafaxine Hydrochloride; Visual Cortex	2013
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Psychological medicine, 2013, Volume: 43, Issue:5 Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (Abingdon, England), 2013, Volume: 108, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride	2013
Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial. The journal of ECT, 2013, Volume: 29, Issue:2 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride	2013
Efficacy and safety of desvenlafaxine 25 and 50▒mg/day in a randomized, placebo-controlled study of depressed outpatients. Journal of psychiatric practice, 2013, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2013
Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:5 Topics: Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bone Resorption; Collagen Type I; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013
Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study. Clinical therapeutics, 2002, Volume: 24, Issue:7 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2002
Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response. Neuropsychobiology, 2002, Volume: 46, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:6 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2002
Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:4 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2002
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry, 2002, Volume: 35, Issue:6 Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Body Weight; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Leptin; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride	2002
Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Single-Blind Method; Venlafaxine Hydrochloride	2003
Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity. Pharmacopsychiatry, 2003, Volume: 36, Issue:5 Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2003
Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients. International journal of geriatric psychiatry, 2004, Volume: 19, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Hospitalization; Humans; Male; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride	2004
Venlafaxine versus placebo in the preventive treatment of recurrent major depression. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3 Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Observer Variation; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
Reboxetine adjunct for partial or nonresponders to antidepressant treatment. Journal of affective disorders, 2004, Volume: 81, Issue:1 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Predictors of improved mood over time in clinical trials for major depression. Psychiatry research, 2004, Jun-30, Volume: 127, Issue:1-2 Topics: Adult; Affect; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Surveys and Questionnaires; Venlafaxine Hydrochloride	2004
Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes. Psychiatry research, 2004, Sep-30, Volume: 128, Issue:2 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Second-Generation; Clonidine; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Norepinephrine; Personality Inventory; Pyrimidines; Serotonin; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride	2004
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram. International journal of geriatric psychiatry, 2004, Volume: 19, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Weight; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride	2004
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:6 Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:2 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cyclohexanols; Demography; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics, Nonparametric; Venlafaxine Hydrochloride	2005
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder. PharmacoEconomics, 2005, Volume: 23, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Health Care Costs; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Venlafaxine Hydrochloride	2005
Do venlafaxine XR and paroxetine equally influence negative and positive affect? Journal of affective disorders, 2005, Volume: 85, Issue:3 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Personality Assessment; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2005
Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo. International clinical psychopharmacology, 2005, Volume: 20, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Placebos; Treatment Outcome; Venlafaxine Hydrochloride	2005
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:6 Topics: Ambulatory Care; Antidepressive Agents, Tricyclic; Attitude to Health; Cohort Studies; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride	2005
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Adult; Ambulatory Care; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2005
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12 Topics: Adult; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride	2005
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Psychiatric Status Rating Scales; Tablets; Time Factors; Venlafaxine Hydrochloride	2006
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1 Topics: Ambulatory Care; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2006
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride	2006
A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:4 Topics: Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Venlafaxine Hydrochloride	2006
Differential physiological effects of a low dose and high doses of venlafaxine in major depression. The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Time Factors; Treatment Outcome; Tyramine; Venlafaxine Hydrochloride	2007
Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2006
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression. Depression and anxiety, 2006, Volume: 23, Issue:6 Topics: Benzodiazepines; Brief Psychiatric Rating Scale; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mass Screening; Middle Aged; Olanzapine; Prospective Studies; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Refusal; Venlafaxine Hydrochloride	2006
Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression. Psychoneuroendocrinology, 2006, Volume: 31, Issue:7 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cyclohexanols; Dehydroepiandrosterone; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychological Tests; Remission Induction; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride	2006
The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. International immunopharmacology, 2006, Volume: 6, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Interleukin-12; Male; Middle Aged; Paroxetine; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Venlafaxine Hydrochloride	2006
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Drug Evaluation; Drug Interactions; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Venlafaxine Hydrochloride	2006
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Human psychopharmacology, 2006, Volume: 21, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2006
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. The American journal of psychiatry, 2006, Volume: 163, Issue:8 Topics: Adult; Biomarkers; Brain; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Placebos; Prefrontal Cortex; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride	2006
Escitalopram versus venlafaxine XR in the treatment of depression. International clinical psychopharmacology, 2006, Volume: 21, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2006
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:9 Topics: Age of Onset; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Monitoring; Electrocardiography; Female; Guidelines as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tachycardia; Venlafaxine Hydrochloride	2006
Keeping our eyes on STARD. The American journal of psychiatry, 2006, Volume: 163, Issue:9* Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride	2006
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STARD report. The American journal of psychiatry, 2006, Volume: 163, Issue:9* Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride	2006
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Patient Compliance; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride	2006
Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study. CNS spectrums, 2006, Volume: 11, Issue:12 Suppl 1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; History, Ancient; Humans; Secondary Prevention; Venlafaxine Hydrochloride	2006
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. Depression and anxiety, 2007, Volume: 24, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Inventory; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Human psychopharmacology, 2007, Volume: 22, Issue:1 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Arousal; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Quetiapine Fumarate; Sleep; Treatment Outcome; Venlafaxine Hydrochloride	2007
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:11 Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2006
Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder. CNS spectrums, 2007, Volume: 12, Issue:3 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Severity of Illness Index; Time Factors; Venlafaxine Hydrochloride	2007
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:5 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Leukoaraiosis; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Nortriptyline; Venlafaxine Hydrochloride	2007
Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder. Human psychopharmacology, 2007, Volume: 22, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Statistics as Topic; Venlafaxine Hydrochloride	2007
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:4 Topics: Adolescent; Algorithms; Child; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Placebos; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride	2007
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Journal of psychiatric research, 2008, Volume: 42, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2008
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STARD report. The American journal of psychiatry, 2007, Volume: 164, Issue:5* Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Decision Trees; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride	2007
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. The American journal of psychiatry, 2007, Volume: 164, Issue:5 Topics: Adult; Brain; Cerebral Cortex; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Limbic System; Male; Middle Aged; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2007
A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. Dementia and geriatric cognitive disorders, 2007, Volume: 24, Issue:1 Topics: Aged; Cyclohexanols; Dementia; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2007
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography. Psychopharmacology, 2007, Volume: 193, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Corpus Striatum; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride	2007
A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:5 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome	2007
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2007
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of substance abuse treatment, 2008, Volume: 34, Issue:1 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine-Related Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2008
Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan. Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:4 Topics: Acute Disease; Adult; Asian People; China; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:7 Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outpatients; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:8 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Compounds; Male; Middle Aged; Phenelzine; Recurrence; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride	2007
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder. International clinical psychopharmacology, 2007, Volume: 22, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Sex Factors; Sweating; Treatment Outcome	2007
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:11 Topics: Adult; Ambulatory Care; Antidepressive Agents; Cholesterol, HDL; Cholesterol, LDL; Cyclohexanols; Demography; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Remission Induction; Severity of Illness Index	2007
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:11 Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prevalence; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride	2007
A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:6 Topics: Aged; Antidepressive Agents; Cholinesterase Inhibitors; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	2008
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STARD report. The American journal of psychiatry, 2008, Volume: 165, Issue:3* Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride	2008
Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2008, May-15, Volume: 32, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroid Hormones; Venlafaxine Hydrochloride	2008
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA, 2008, Feb-27, Volume: 299, Issue:8 Topics: Adolescent; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2008
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment	2008
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:3 Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Arousal; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Libido; Male; Middle Aged; Orgasm; Personality Inventory; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride	2008
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Journal of affective disorders, 2009, Volume: 112, Issue:1-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Lithium Compounds; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychometrics; Regression Analysis; Treatment Outcome; Venlafaxine Hydrochloride	2009
Comparison of venlafaxine and imipramine in depressive illness. Acta psychiatrica Scandinavica, 1998, Volume: 97, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Patient Care Team; Treatment Outcome; Venlafaxine Hydrochloride	1998
Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	1998
Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	1998
[The concept of resistant depression and therapeutic strategies, particularly, with venlafaxine]. L'Encephale, 1999, Volume: 25 Spec No 2 Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Humans; Paroxetine; Remission, Spontaneous; Severity of Illness Index; Venlafaxine Hydrochloride	1999
Venlafaxine treatment of cocaine abusers with depressive disorders. The American journal of drug and alcohol abuse, 2000, Volume: 26, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cocaine-Related Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Desipramine; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Treatment Failure; Venlafaxine Hydrochloride	2000
Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia. Journal of psychopharmacology (Oxford, England), 2000, Volume: 14, Issue:1 Topics: Adolescent; Adult; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride	2000
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. Journal of affective disorders, 2000, Volume: 58, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride	2000
Venlafaxine monotherapy in women with bipolar II and unipolar major depression. Journal of affective disorders, 2000, Volume: 59, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Retrospective Studies; Sex Factors; Venlafaxine Hydrochloride	2000
Sustained response to open-label venlafaxine in drug-resistant major depression. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride	2001
Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders. Neuropsychobiology, 2001, Volume: 44, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Serotonin; Treatment Outcome; Venlafaxine Hydrochloride	2001
Changes in brain function of depressed subjects during treatment with placebo. The American journal of psychiatry, 2002, Volume: 159, Issue:1 Topics: Adult; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Placebo Effect; Venlafaxine Hydrochloride	2002
Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 27, Issue:1 Topics: Adult; Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Prefrontal Cortex; Single-Blind Method; Venlafaxine Hydrochloride	2002

Other Studies

201 other study(ies) available for cyclohexanol and Depression, Involutional

Article	Year
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder. The international journal of neuropsychopharmacology, 2022, 04-19, Volume: 25, Issue:4 Topics: Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Cyclohexanols; Depressive Disorder, Major; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tyramine; Venlafaxine Hydrochloride	2022
What next? A Bayesian hierarchical modeling re-examination of treatments for adolescents with selective serotonin reuptake inhibitor-resistant depression. Depression and anxiety, 2020, Volume: 37, Issue:9 Topics: Adolescent; Bayes Theorem; Cyclohexanols; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2020
Comparison of venlafaxine alone versus venlafaxine plus late partial sleep deprivation therapy combination for major depressive disorder. Chronobiology international, 2021, Volume: 38, Issue:3 Topics: Circadian Rhythm; Cyclohexanols; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Sleep Deprivation; Treatment Outcome; Venlafaxine Hydrochloride	2021
Venlafaxine-related akathisia side-effects and management in a depressed patient. Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Venlafaxine Hydrochloride	2013
Psychomotor depressive symptoms may differentially respond to venlafaxine. International clinical psychopharmacology, 2013, Volume: 28, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2013
Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:2 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Risk Factors; Treatment Failure; Venlafaxine Hydrochloride	2013
Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptoms. Neuroreport, 2013, May-08, Volume: 24, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Cohort Studies; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	2013
Severe tremor after cotrimoxazole-induced elevation of venlafaxine serum concentrations in a patient with major depressive disorder. Therapeutic drug monitoring, 2013, Volume: 35, Issue:3 Topics: Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Drug Interactions; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tremor; Trimethoprim, Sulfamethoxazole Drug Combination; Venlafaxine Hydrochloride	2013
Dose-related paresthesias with venlafaxine. Journal of pharmacy practice, 2013, Volume: 26, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Paresthesia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013
Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder. International journal of methods in psychiatric research, 2013, Volume: 22, Issue:3 Topics: Adolescent; Adult; Age Factors; Caregivers; Cluster Analysis; Cyclohexanols; Data Mining; Decision Making; Delayed-Action Preparations; Depressive Disorder, Major; Drug Costs; Duloxetine Hydrochloride; Female; Health Education; Humans; Insurance Claim Reporting; Male; Middle Aged; Observational Studies as Topic; Outcome and Process Assessment, Health Care; Statistics as Topic; Statistics, Nonparametric; Thiophenes; Venlafaxine Hydrochloride; Young Adult	2013
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression. The journal of ECT, 2013, Volume: 29, Issue:3 Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Cyclophosphamide; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lupus Erythematosus, Systemic; Olanzapine; Prednisolone; Venlafaxine Hydrochloride	2013
Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression. Human psychopharmacology, 2013, Volume: 28, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Asian People; Citalopram; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Serotonin Plasma Membrane Transport Proteins; Single-Blind Method; Time Factors; Venlafaxine Hydrochloride; White People; Young Adult	2013
Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2014, Volume: 15, Issue:5 Topics: Aged; Bone Resorption; Cyclohexanols; Depressive Disorder, Major; Female; Genetic Variation; Humans; Male; Middle Aged; Osteogenesis; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride	2014
[Antidepressant treatment associated hyponatremia -- case report]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2013, Volume: 15, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride	2013
When depression doesn't lead with depression. JAMA psychiatry, 2013, Volume: 70, Issue:11 Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride	2013
High impact child abuse may predict risk of elevated suicidality during antidepressant initiation. The Australian and New Zealand journal of psychiatry, 2013, Volume: 47, Issue:12 Topics: Adult; Adult Survivors of Child Abuse; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Risk Factors; Suicidal Ideation; Suicide, Attempted; Venlafaxine Hydrochloride	2013
Acute bilateral parotitis occurring during venlafaxine titration in an adolescent female with major depression. Pharmacopsychiatry, 2014, Volume: 47, Issue:1 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Parotitis; Pregnancy; Venlafaxine Hydrochloride; Young Adult	2014
Case report of a 24-year-old man with resolution of treatment-resistant major depressive disorder and comorbid PTSD using rTMS. The journal of ECT, 2014, Volume: 30, Issue:1 Topics: Antidepressive Agents, Second-Generation; Combat Disorders; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Humans; Male; Military Personnel; Stress Disorders, Post-Traumatic; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride; Young Adult	2014
Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression. International journal of psychiatry in clinical practice, 2014, Volume: 18, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Catechol O-Methyltransferase; Cyclohexanols; Depressive Disorder, Major; Epistasis, Genetic; Female; Humans; Male; Middle Aged; Paroxetine; Receptors, Dopamine D2; Republic of Korea; Treatment Outcome; Venlafaxine Hydrochloride	2014
Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder. CNS spectrums, 2014, Volume: 19, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2014
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride	2014
Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. Journal of the American Psychoanalytic Association, 2014, Volume: 62, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Brief; Sertraline	2014
An observational study of Venlafaxine and CYP2D6 in clinical practice. Clinical laboratory, 2014, Volume: 60, Issue:2 Topics: Adult; Aged; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phenotype; Practice Patterns, Physicians'; Venlafaxine Hydrochloride	2014
Long-standing depression and anxiety in a Korean woman. The American journal of psychiatry, 2014, Volume: 171, Issue:6 Topics: Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Republic of Korea; Venlafaxine Hydrochloride	2014
But does it work in women like me? Menopause (New York, N.Y.), 2014, Volume: 21, Issue:8 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Humans; Menopause	2014
Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride	2015
The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder. The journal of headache and pain, 2014, Nov-10, Volume: 15 Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Disease Management; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Pain Measurement; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2014
SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population. Journal of psychiatric research, 2015, Volume: 61 Topics: Adult; Asian People; Cyclohexanols; Depressive Disorder, Major; Female; Genetic Testing; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Polymorphism, Single Nucleotide; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
More data on speed of remission with ECT in geriatric depression. The British journal of psychiatry : the journal of mental science, 2015, Volume: 206, Issue:2 Topics: Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline	2015
Authors' reply. The British journal of psychiatry : the journal of mental science, 2015, Volume: 206, Issue:2 Topics: Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline	2015
A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women. Journal of women's health (2002), 2015, Volume: 24, Issue:4 Topics: Administration, Oral; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Menopause; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome	2015
Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression. BMC bioinformatics, 2015, Apr-03, Volume: 16 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Gene Regulatory Networks; Humans; Leukocytes, Mononuclear; Male; Microarray Analysis; Venlafaxine Hydrochloride	2015
[Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Molecular psychiatry, 2016, Volume: 21, Issue:4 Topics: Adult; Affect; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride	2016
A breakthrough treatment for major depression. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:5 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Phototherapy	2015
Circadian rhythms and mood disorders: a guide for the perplexed. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:5 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Phototherapy	2015
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here? The American journal of psychiatry, 2015, Aug-01, Volume: 172, Issue:8 Topics: Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Sertraline	2015
SSRIs have a smaller benefit in paediatric when compared to adult major depressive disorder. Evidence-based mental health, 2016, Volume: 19, Issue:1 Topics: Adult; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors	2016
Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder. Journal of managed care pharmacy : JMCP, 2008, Volume: 14, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Databases, Factual; Depressive Disorder, Major; Drug Costs; Drug Utilization; Female; Health Care Costs; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:4 Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Cohort Studies; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; England; Female; Hospital Costs; Humans; Length of Stay; Male; Middle Aged; Referral and Consultation; Retrospective Studies; Venlafaxine Hydrochloride	2008
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. Journal of neurochemistry, 2008, Volume: 106, Issue:6 Topics: Analgesics; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Cyclohexanols; Depressive Disorder, Major; Disease Models, Animal; Endocannabinoids; Imipramine; Male; Motivation; Polyunsaturated Alkamides; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Sexual Behavior, Animal; Stress, Psychological	2008
Flat dose-response curves for efficacy: what do they mean to the clinician? Journal of psychiatric practice, 2008, Volume: 14, Issue:4 Topics: Attitude of Health Personnel; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Physicians; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; United States; United States Food and Drug Administration	2008
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions? The Journal of clinical psychiatry, 2008, Volume: 69, Issue:5 Topics: Cyclohexanols; Depressive Disorder, Major; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2008
Identifying patients at risk of complete nonresponse in the outpatient treatment of depression. Psychotherapy and psychosomatics, 2008, Volume: 77, Issue:6 Topics: Adolescent; Adult; Aged; Ambulatory Care; Amitriptyline; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Female; Humans; Male; Middle Aged; Nortriptyline; Psychotherapy; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult	2008
[The place of escitalopram in the severe depressive episodes]. L'Encephale, 2008, Volume: 34 Suppl 3 Topics: Age Factors; Citalopram; Cyclohexanols; Depressive Disorder, Major; Humans; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
[A place for SSRIs in the treatment of severely depressed children and adolescents]. Nederlands tijdschrift voor geneeskunde, 2008, Aug-02, Volume: 152, Issue:31 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Venlafaxine Hydrochloride	2008
[Hypomania/mania induced by cessation of antidepressant drugs]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2008,Fall, Volume: 19, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2008
Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride	2008
[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Mirtazapine; Venlafaxine Hydrochloride	2008
The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:7 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Economics, Pharmaceutical; Fluoxetine; Focus Groups; Humans; Models, Theoretical; Psychometrics; Selective Serotonin Reuptake Inhibitors; Thailand; Venlafaxine Hydrochloride	2008
Venlafaxine-induced excessive yawning. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Feb-01, Volume: 33, Issue:1 Topics: Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Yawning; Young Adult	2009
Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:1 Topics: Animals; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Humans; Menopause; Molecular Structure; Neuralgia; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Vasomotor System	2009
New technologies: the good, the bad, and the ugly. CNS spectrums, 2009, Volume: 14, Issue:1 Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desvenlafaxine Succinate; Gene Expression Profiling; Humans; Oligonucleotide Array Sequence Analysis	2009
Psychosis in the elderly. The American journal of psychiatry, 2009, Volume: 166, Issue:2 Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Combined Modality Therapy; Comorbidity; Cyclohexanols; Delirium; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Memantine; Nootropic Agents; Piperazines; Psychotherapy; Psychotic Disorders; Quinolones; Risk Factors; Treatment Outcome; Venlafaxine Hydrochloride	2009
Taurine transporter in lymphocytes of patients with major depression treated with venlafaxine plus psychotherapy. Advances in experimental medicine and biology, 2009, Volume: 643 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Depressive Disorder, Major; Humans; Interleukin-2; Interleukin-4; Lymphocytes; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Venlafaxine Hydrochloride	2009
Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder. Depression and anxiety, 2009, Volume: 26, Issue:6 Topics: Adolescent; Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; Male; Middle Aged; Observer Variation; Personality Inventory; Psychometrics; Pyridines; Reproducibility of Results; Somatoform Disorders; Taiwan; Venlafaxine Hydrochloride; Young Adult; Zolpidem	2009
Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK. Clinical drug investigation, 2009, Volume: 29, Issue:3 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Delphi Technique; Depressive Disorder, Major; Drug Costs; Drugs, Generic; Fluoxetine; Humans; Psychiatric Status Rating Scales; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride	2009
Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Buspirone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Severity of Illness Index; Sleep Bruxism; Treatment Outcome; Venlafaxine Hydrochloride	2010
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Olanzapine; Personality Inventory; Psychometrics; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2009
Major depression, antidepressant medication and the risk of obesity. Psychotherapy and psychosomatics, 2009, Volume: 78, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Incidence; Male; Middle Aged; Obesity; Risk Factors; Venlafaxine Hydrochloride; Young Adult	2009
Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting. Nordic journal of psychiatry, 2009, Volume: 63, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Denmark; Depressive Disorder, Major; Dothiepin; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	2009
Venlafaxine-induced complex visual hallucinations in a 17-year-old boy. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:4 Topics: Adolescent; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Hallucinations; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2009
Antidepressant switching among adherent patients treated for depression. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult	2009
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs". Biological psychiatry, 2009, Sep-01, Volume: 66, Issue:5 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Meta-Analysis as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2009
Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine. Acta psychiatrica Scandinavica, 2009, Volume: 120, Issue:4 Topics: Adult; Clomipramine; Cyclohexanols; Delusions; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2009
Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials. Postgraduate medicine, 1999, Volume: 106, Issue:6 Suppl Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women? The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2 Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Climacteric; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Morpholines; Personality Inventory; Reboxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult	2009
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy. Acta psychiatrica Scandinavica, 2010, Volume: 121, Issue:3 Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2010
Cortisol metabolism in depressed patients and healthy controls. Neuroendocrinology, 2009, Volume: 90, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cortisone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Mianserin; Middle Aged; Mirtazapine; Tetrahydrocortisol; Tetrahydrocortisone; Venlafaxine Hydrochloride; Young Adult	2009
Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo. Psychopharmacology bulletin, 2009, Volume: 42, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. International clinical psychopharmacology, 2009, Volume: 24, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome	2009
The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step. Depression and anxiety, 2009, Volume: 26, Issue:10 Topics: Adolescent; Antidepressive Agents; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Fluoxetine; Humans; Male; Multicenter Studies as Topic; Paroxetine; Personality Assessment; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; Venlafaxine Hydrochloride	2009
Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Topics: Actigraphy; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motor Activity; Personality Inventory; Prognosis; Prospective Studies; Quetiapine Fumarate; Signal Processing, Computer-Assisted; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride	2009
Neurotrophic factors in serum following ECT: a pilot study. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Growth Factors; Pilot Projects; Psychotherapy; Psychotropic Drugs; Recurrence; Reference Values; Venlafaxine Hydrochloride	2009
Pro-inflammatory biomakers in depression: treatment with venlafaxine. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Inflammation Mediators; Male; Middle Aged; Personality Inventory; Reference Values; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Mania possibly induced by desvenlafaxine. Journal of psychiatric practice, 2010, Volume: 16, Issue:1 Topics: Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Male; Middle Aged	2010
Combining antidepressant medications: a good idea? The American journal of psychiatry, 2010, Volume: 167, Issue:3 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2010
Management of depression in the presence of pain symptoms. Psychiatria Danubina, 2010, Volume: 22, Issue:1 Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2010
Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sex Factors; Statistics as Topic; Treatment Outcome; Young Adult	2010
Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry. Journal of psychiatric practice, 2010, Volume: 16, Issue:3 Topics: Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Humans; Mental Disorders; Metabolic Clearance Rate; Pharmacogenetics; Phenotype; Psychotropic Drugs; Treatment Outcome; Venlafaxine Hydrochloride	2010
Antidepressant "treatment". Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4 Topics: Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Middle Aged; Neurotransmitter Uptake Inhibitors; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors	2010
Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression. Psychiatria Danubina, 2010, Volume: 22, Issue:2 Topics: Affective Disorders, Psychotic; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Combat Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Personality Disorders; Quetiapine Fumarate; Secondary Prevention; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride; Veterans	2010
Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Humans; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Suicide; Suicide, Attempted; Young Adult	2010
Treatment of psychotic depression in the elderly compared with nonpsychotic depression. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Follow-Up Studies; Humans; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2010
Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2010
Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine. Neuropsychobiology, 2010, Volume: 62, Issue:3 Topics: Adult; Alleles; Asian People; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride	2010
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden. Journal of medical economics, 2010, Volume: 13, Issue:3 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Markov Chains; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sweden; Thiophenes; Venlafaxine Hydrochloride	2010
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study. Journal of psychiatric research, 2011, Volume: 45, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Female; Fluoxetine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult	2011
HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder. Pharmacopsychiatry, 2010, Volume: 43, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Young Adult	2010
The bipolar spectrum: do we need a single algorithm for affective disorders? Psychiatria Danubina, 2010, Volume: 22, Issue:3 Topics: Algorithms; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Humans; Practice Guidelines as Topic; Primary Health Care; Referral and Consultation; Risk Factors; Venlafaxine Hydrochloride	2010
Gambling on acamprosate: a case report. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:9 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Middle Aged; Taurine; Treatment Outcome; Venlafaxine Hydrochloride	2010
Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences. Current medical research and opinion, 2010, Volume: 26, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Drug Combinations; Drug Costs; Female; Health Care Costs; Health Resources; Humans; Male; Retrospective Studies; Spain; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2010
A case of venlafaxine-induced bruxism alleviated by duloxetine substitution. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jan-15, Volume: 35, Issue:1 Topics: Aged; Antidepressive Agents; Bruxism; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Thiophenes; Venlafaxine Hydrochloride	2011
Tolerance to desvenlafaxine in rapid metabolizing depressed patients. International clinical psychopharmacology, 2011, Volume: 26, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Tolerance; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic	2011
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder. BMC psychiatry, 2011, Jan-31, Volume: 11 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Costs; Duloxetine Hydrochloride; Female; Health Care Costs; Humans; Male; Middle Aged; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2011
Paliperidone augmentation for treatment-resistant depression: a case report. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2 Topics: Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Treatment Outcome; Venlafaxine Hydrochloride	2011
Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2011, Volume: 7, Issue:3 Topics: Abdominal Pain; Adult; Bezoars; Colectomy; Cyclohexanols; Depressive Disorder, Major; Edema; Emergency Medical Services; Female; Humans; Ileocecal Valve; Intestinal Obstruction; Laparotomy; Necrosis; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Tachycardia; Venlafaxine Hydrochloride	2011
Venlafaxine withdrawal syndrome. Psychiatria Danubina, 2011, Volume: 23, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Ischemic Attack, Transient; Retreatment; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2011
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases. Current medical research and opinion, 2011, Volume: 27, Issue:7 Topics: Adolescent; Adult; Algorithms; Antidepressive Agents; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dosage Forms; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Pain; Retrospective Studies; Somatoform Disorders; Thiophenes; Venlafaxine Hydrochloride; Young Adult	2011
Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study. Psychiatry research, 2011, Sep-30, Volume: 189, Issue:2 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; CREB-Binding Protein; Cyclohexanols; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Hydrocortisone; Lymphocytes; Male; Middle Aged; Pilot Projects; Receptors, Glucocorticoid; Time Factors; Venlafaxine Hydrochloride	2011
Electroconvulsive therapy in older adults. Medicine and health, Rhode Island, 2011, Volume: 94, Issue:4 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Retreatment; Venlafaxine Hydrochloride	2011
Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Aug-15, Volume: 35, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Inpatients; Israel; Male; Medical Records Systems, Computerized; Middle Aged; Psychiatric Status Rating Scales; Receptors, Adrenergic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder. International journal of clinical pharmacology and therapeutics, 2011, Volume: 49, Issue:7 Topics: Adolescent; Adult; Aged; Analysis of Variance; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hyponatremia; Male; Mianserin; Middle Aged; Mirtazapine; Republic of Korea; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride; Young Adult	2011
Proinflammatory and "resiliency" proteins in the CSF of patients with major depression. Depression and anxiety, 2012, Volume: 29, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Interleukin-6; Male; Middle Aged; Neuropeptide Y; Severity of Illness Index; Tumor Necrosis Factor-alpha; Up-Regulation; Venlafaxine Hydrochloride	2012
Measuring adherence in TORDIA. Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:10 Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Monitoring; Female; Humans; Male; Medication Adherence; Selective Serotonin Reuptake Inhibitors	2011
Measuring adherence in TORDIA. Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:10 Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Monitoring; Female; Humans; Male; Medication Adherence; Selective Serotonin Reuptake Inhibitors	2011
Venlafaxin-associated post-ictal asystole during electroconvulsive therapy. Pharmacopsychiatry, 2012, Volume: 45, Issue:3 Topics: Aged, 80 and over; Bipolar Disorder; Contraindications; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Heart Arrest; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Approval; Female; Humans; Male; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Sertraline; United States Food and Drug Administration; Venlafaxine Hydrochloride	2012
Optimized light therapy for non-seasonal major depressive disorder: effects of timing and season. Journal of affective disorders, 2012, Volume: 138, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phototherapy; Seasons; Time Factors; Venlafaxine Hydrochloride	2012
Saving lives: can we predict and prevent adolescent suicide? Journal of the American Academy of Child and Adolescent Psychiatry, 2012, Volume: 51, Issue:4 Topics: Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Joy returns last: anhedonia and treatment resistance in depressed adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 2012, Volume: 51, Issue:4 Topics: Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Fatal agranulocytosis associated with psychotropic medication use. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, May-15, Volume: 69, Issue:10 Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Cell Count; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Fatal Outcome; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lamotrigine; Mianserin; Mirtazapine; Multiple Organ Failure; Neutropenia; Orbital Cellulitis; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Recombinant Proteins; Shock, Septic; Triazines; Venlafaxine Hydrochloride	2012
5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study. The journal of sexual medicine, 2012, Volume: 9, Issue:8 Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Prospective Studies; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride; Young Adult	2012
Evidence for short-term psychodynamic psychotherapy for depression. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Psychotherapy, Brief; Sertraline	2012
Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. Journal of affective disorders, 2013, Apr-05, Volume: 146, Issue:2 Topics: Adult; Antidepressive Agents; Case-Control Studies; Corticotropin-Releasing Hormone; Cyclohexanols; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Metabolites: novel therapeutics or "me-too" drugs? Using desvenlafaxine as an example. CNS spectrums, 2012, Volume: 17, Issue:3 Topics: Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Meta-Analysis as Topic	2012
An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator. CNS spectrums, 2012, Volume: 17, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Australia; Bayes Theorem; Cyclohexanols; Databases, Factual; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nausea; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STARD trial. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95 Suppl 5* Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Models, Economic; Quality of Life; Sertraline; Thailand; Venlafaxine Hydrochloride	2012
The challenge of treating (and supervising) patients with borderline pathology in a residents' clinic. Psychodynamic psychiatry, 2012, Volume: 40, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Borderline Personality Disorder; Countertransference; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Internship and Residency; Prescription Drug Misuse; Psychiatry; Psychotherapy; Pyridines; Self-Injurious Behavior; Transference, Psychology; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult; Zolpidem	2012
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride	2012
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression. Translational psychiatry, 2012, Nov-27, Volume: 2 Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Heterozygote; Humans; Male; Polymorphism, Single Nucleotide; Predictive Value of Tests; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride	2012
A case of high-dose venlafaxine-related psychosis. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression. Journal of affective disorders, 2013, Volume: 148, Issue:2-3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Inappropriate data and measures lead to questionable conclusions. JAMA psychiatry, 2013, Volume: 70, Issue:1 Topics: Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide	2013
Inappropriate data and measures lead to questionable conclusions--reply. JAMA psychiatry, 2013, Volume: 70, Issue:1 Topics: Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide	2013
Suicide risk and efficacy of antidepressant drugs. JAMA psychiatry, 2013, Volume: 70, Issue:1 Topics: Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide	2013
Suicide risk and efficacy of antidepressant drugs--reply. JAMA psychiatry, 2013, Volume: 70, Issue:1 Topics: Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide	2013
Treatment of posttraumatic stress disorder with tiagabine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:8 Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Nipecotic Acids; Stress Disorders, Post-Traumatic; Tiagabine; Treatment Outcome; Venlafaxine Hydrochloride	2002
The brain tells: early signs of depression recovery. The Harvard mental health letter, 2002, Volume: 19, Issue:5 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Prefrontal Cortex; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Venlafaxine Hydrochloride	2002
The neural substrates of affective processing in depressed patients treated with venlafaxine. The American journal of psychiatry, 2003, Volume: 160, Issue:1 Topics: Adult; Affect; Amygdala; Brain Mapping; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Treatment Outcome; Venlafaxine Hydrochloride	2003
Gabapentin and posttraumatic stress disorder. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:5 Topics: Acetates; Adult; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanecarboxylic Acids; Cyclohexanols; Depressive Disorder, Major; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride	2003
Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:1 Topics: Administration, Oral; Adult; Clomipramine; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2004
Venlafaxine withdrawal syndrome: report of seven cases in Trinidad. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Trinidad and Tobago; Venlafaxine Hydrochloride	2004
Elevated defibrillation threshold with venlafaxine therapy. Pharmacotherapy, 2004, Volume: 24, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Defibrillators, Implantable; Depressive Disorder, Major; Equipment Failure; Female; Heart Arrest; Humans; Venlafaxine Hydrochloride	2004
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5 Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Buspirone to improve compliance in venlafaxine-induced movement disorder. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4 Topics: Antidepressive Agents, Second-Generation; Buspirone; Compliance; Cyclohexanols; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Serotonin Receptor Agonists; Venlafaxine Hydrochloride	2004
[Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy]. Der Nervenarzt, 2005, Volume: 76, Issue:5 Topics: Aged; Chemotherapy, Adjuvant; Cyclohexanols; Depressive Disorder, Major; Drug Combinations; Female; Glucocorticoids; Humans; Prednisolone; Severity of Illness Index; Thyroiditis, Autoimmune; Treatment Outcome; Venlafaxine Hydrochloride	2005
A possible case of venlafaxine-induced Stevens-Johnson syndrome. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Exanthema; Female; Humans; Methylprednisolone; Selective Serotonin Reuptake Inhibitors; Stevens-Johnson Syndrome; Treatment Outcome; Venlafaxine Hydrochloride	2004
Medication-associated somnambulism. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:3 Topics: Adolescent; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Pyridines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Somnambulism; Venlafaxine Hydrochloride; Zolpidem	2005
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium. Clinical therapeutics, 2005, Volume: 27, Issue:1 Topics: Antidepressive Agents, Second-Generation; Belgium; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Costs; Humans; Models, Economic; Practice Patterns, Physicians'; Treatment Outcome; Venlafaxine Hydrochloride	2005
Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients. Journal of affective disorders, 2005, Volume: 85, Issue:3 Topics: Adult; Aged; Bipolar Disorder; Blood Glucose; Brain; Brain Diseases, Metabolic; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucans; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Psychotic Disorders; Psychotropic Drugs; Reference Values; Risk Factors; Sorbitol; Statistics as Topic; Venlafaxine Hydrochloride	2005
Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epistaxis; Gastrointestinal Hemorrhage; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2005
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. Journal of sleep research, 2005, Volume: 14, Issue:2 Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Narcolepsy; Polysomnography; Substance Withdrawal Syndrome; Treatment Failure; Venlafaxine Hydrochloride	2005
Adolescents' response to antidepressant treatment in a community mental health center. Community mental health journal, 2005, Volume: 41, Issue:1 Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2005
Multimodal therapy of treatment resistant depression: a study and analysis. International journal of psychiatry in medicine, 2005, Volume: 35, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Culture; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Humans; Self Concept; Severity of Illness Index; Venlafaxine Hydrochloride	2005
Olanzapine plus venlafaxine in treatment-resistant depression. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:4 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Olanzapine; Venlafaxine Hydrochloride	2005
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. Journal of women's health (2002), 2005, Volume: 14, Issue:7 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Time Factors; Venlafaxine Hydrochloride	2005
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2005
Venlafaxine and asthma. Nordic journal of psychiatry, 2005, Volume: 59, Issue:6 Topics: Asthma; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2005
Venlafaxine and the rapid development of anasarca. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Edema; Female; Humans; Vasomotor System; Venlafaxine Hydrochloride	2006
Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2006
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:13 Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2005
CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly. International journal of geriatric psychiatry, 2006, Volume: 21, Issue:6 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Creatinine; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Venlafaxine Hydrochloride	2006
[Love, humor and psychosis in an atypical depression]. L'Encephale, 2005, Volume: 31 Pt 2 Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic	2005
Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine. Perspectives in psychiatric care, 2006, Volume: 42, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride	2006
Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder. The Journal of neuropsychiatry and clinical neurosciences, 2006,Spring, Volume: 18, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperkinesis; Modafinil; Neurologic Examination; Venlafaxine Hydrochloride	2006
Lithium and venlafaxine interaction: a case of serotonin syndrome. Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:4 Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Female; Humans; Lithium Carbonate; Serotonin Syndrome; Venlafaxine Hydrochloride	2006
Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods? Journal of affective disorders, 2007, Volume: 99, Issue:1-3 Topics: Adult; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Dexamethasone; Dexfenfluramine; Dominance, Cerebral; Electrooculography; Electroretinography; Evoked Potentials, Visual; Female; Follow-Up Studies; Globus Pallidus; Humans; Hydrocortisone; Male; Middle Aged; Prognosis; Prolactin; Recurrence; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride	2007
Topiramate use in alprazolam addiction. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2006, Volume: 7, Issue:4 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Fructose; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Topiramate; Treatment Outcome; Venlafaxine Hydrochloride	2006
Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR. Current medical research and opinion, 2006, Volume: 22, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Databases as Topic; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Regression Analysis; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2006
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression. Journal of affective disorders, 2007, Volume: 101, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Emotions; Female; Fluoxetine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Mental Recall; Middle Aged; Paired-Associate Learning; Personality Inventory; Positron-Emission Tomography; Semantics; Sertraline; Venlafaxine Hydrochloride; Wechsler Scales	2007
STARD: what have we learned? The American journal of psychiatry, 2007, Volume: 164, Issue:2* Topics: Ambulatory Care; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Follow-Up Studies; Humans; Lithium Compounds; Randomized Controlled Trials as Topic; Research Design; Secondary Prevention; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride	2007
Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid. The American journal of psychiatry, 2007, Volume: 164, Issue:2 Topics: Acetamides; Adult; Anti-Infective Agents; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Female; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Serotonin Syndrome; Venlafaxine Hydrochloride	2007
Venlafaxine for major depression. BMJ (Clinical research ed.), 2007, Feb-03, Volume: 334, Issue:7587 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Venlafaxine Hydrochloride	2007
Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis. Psychiatry research, 2007, Feb-28, Volume: 154, Issue:2 Topics: Adult; Affect; Biogenic Monoamines; Brain Stem; Caudate Nucleus; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorodeoxyglucose F18; Fluoxetine; Gyrus Cinguli; Hippocampus; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Positron-Emission Tomography; Psychomotor Disorders; Putamen; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2007
Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism. Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Haloperidol; Humans; Lewy Body Disease; Neostriatum; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride	2007
Antidepressant response in the elderly. Psychiatry research, 2007, Jul-30, Volume: 152, Issue:1 Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2007
Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths. Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:4 Topics: Adolescent; Child; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Female; Human Experimentation; Humans; Male; Research Design; Risk Factors; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride	2007
A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care. Nordic journal of psychiatry, 2007, Volume: 61, Issue:2 Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Denmark; Depressive Disorder, Major; Drug Costs; Humans; Models, Economic; Practice Patterns, Physicians'; Primary Health Care; Remission Induction; Venlafaxine Hydrochloride	2007
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatry research, 2007, Aug-30, Volume: 152, Issue:2-3 Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride	2007
Non-pharmacological treatment of psychiatrists in addition to the prescribing of an antidepressant drug. European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:7 Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Counseling; Cyclohexanols; Depressive Disorder, Major; Drug Prescriptions; Female; Humans; Male; Middle Aged; Physicians; Psychiatry; Psychotherapy; Sex Factors; Venlafaxine Hydrochloride	2007
Using psychostimulants for treating residual symptoms in major depression. Journal of psychiatry & neuroscience : JPN, 2007, Volume: 32, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Modafinil; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2007
Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine. The British journal of dermatology, 2007, Volume: 157, Issue:4 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Eruptions; Female; Humans; Middle Aged; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Telangiectasis; Venlafaxine Hydrochloride	2007
Cytochrome P450 2D6 genotype variation and venlafaxine dosage. Mayo Clinic proceedings, 2007, Volume: 82, Issue:9 Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depressive Disorder, Major; Dysthymic Disorder; Female; Genotype; Humans; Male; Middle Aged; Retrospective Studies; Treatment Failure; Venlafaxine Hydrochloride	2007
Venlafaxine-lithium toxicity: suitability for use in the elderly. Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:5 Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Female; Humans; Lithium Compounds; Risk; Serotonin Syndrome; Venlafaxine Hydrochloride	2007
Successful duloxetine use to prevent venlafaxine withdrawal symptoms. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Venlafaxine Hydrochloride	2008
Sertraline versus venlafaxine XR in major depressive disorder. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10 Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2007
Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Hypotension; Polymorphism, Genetic; Receptors, Adrenergic, alpha-2; Venlafaxine Hydrochloride	2008
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1 Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Interview, Psychological; Male; Mood Disorders; Patient Readmission; Prevalence; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Venlafaxine Hydrochloride	2008
A case of extreme paradoxical insomnia responding selectively to electroconvulsive therapy. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008, Feb-15, Volume: 4, Issue:1 Topics: Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dibenzothiazepines; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Middle Aged; Quetiapine Fumarate; Sick Role; Sleep Initiation and Maintenance Disorders; Suicide; Suicide Prevention; Venlafaxine Hydrochloride	2008
Similar effects of tramadol and venlafaxine in major depressive disorder. Southern medical journal, 2008, Volume: 101, Issue:2 Topics: Adult; Analgesics, Opioid; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Low Back Pain; Selective Serotonin Reuptake Inhibitors; Tramadol; Venlafaxine Hydrochloride	2008
Asystole during electroconvulsive therapy in an elderly woman treated concomitantly with venlafaxine. The Australian and New Zealand journal of psychiatry, 2008, Volume: 42, Issue:3 Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Heart Arrest; Humans; Venlafaxine Hydrochloride	2008
Venlafaxine: Successful treatment in impulsive disorders. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Compulsive Behavior; Cyclohexanols; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride	2008
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. European psychiatry : the journal of the Association of European Psychiatrists, 2008, Volume: 23, Issue:5 Topics: Adolescent; Adult; Cyclohexanols; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Middle Aged; Personality Disorders; Predictive Value of Tests; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride	2008
Desvenlafaxine for depression. The Medical letter on drugs and therapeutics, 2008, May-19, Volume: 50, Issue:1286 Topics: Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Interactions; Humans; Neurotransmitter Uptake Inhibitors	2008
The review by Weinmann and colleagues. Psychopharmacology, 2008, Volume: 199, Issue:1 Topics: Antidepressive Agents, Second-Generation; Bias; Cyclohexanols; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders. International journal of psychiatry in medicine, 1997, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Risk Factors; Venlafaxine Hydrochloride	1997
Use of bupropion with SRIs and venlafaxine. Depression and anxiety, 1998, Volume: 7, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1998
Lithium augmentation of venlafaxine in adolescent major depression. The Australian and New Zealand journal of psychiatry, 1998, Volume: 32, Issue:3 Topics: Adolescent; Antidepressive Agents; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Psychotherapy; Treatment Outcome; Venlafaxine Hydrochloride	1998
Venlafaxine: new preparation. Just another antidepressant. Prescrire international, 1998, Volume: 7, Issue:36 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Evaluation; Fluoxetine; Humans; Imipramine; Meta-Analysis as Topic	1998
An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms. Journal of psychopharmacology (Oxford, England), 1999, Volume: 13, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Coronary Circulation; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electrocardiography; Female; Humans; Myocardial Infarction; Norepinephrine; Platelet Aggregation; Serotonin; Venlafaxine Hydrochloride	1999
Abnormal clotting and production of factor VIII inhibitor in a patient treated with venlafaxine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999, Volume: 44, Issue:9 Topics: Blood Coagulation Disorders; Cyclohexanols; Depressive Disorder, Major; Factor VIII; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment. The European respiratory journal, 2000, Volume: 15, Issue:1 Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Biopsy; Cyclohexanols; Depressive Disorder, Major; Humans; Lung; Male; Prednisone; Pulmonary Eosinophilia; Respiratory Insufficiency; Tomography, X-Ray Computed; Venlafaxine Hydrochloride	2000
Defense mechanisms and personality in depression. Depression and anxiety, 1999, Volume: 10, Issue:4 Topics: Adult; Antidepressive Agents; Cyclohexanols; Defense Mechanisms; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Patient Dropouts; Personality Disorders; Predictive Value of Tests; Psychiatric Status Rating Scales; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	1999
Critical use of venlafaxine serology to uncover genetic rapid metabolism. The Journal of neuropsychiatry and clinical neurosciences, 2001,Winter, Volume: 13, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Treatment Outcome; Venlafaxine Hydrochloride	2001
Lithium augmentation in venlafaxine-refractory depression. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2 Topics: Antimanic Agents; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Prefrontal changes and treatment response prediction in depression. Seminars in clinical neuropsychiatry, 2001, Volume: 6, Issue:2 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride	2001
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:2 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2002
Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression. The Journal of neuropsychiatry and clinical neurosciences, 2002,Spring, Volume: 14, Issue:2 Topics: Aged; Anesthetics, Intravenous; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Electroconvulsive Therapy; Female; Heart Arrest; Heart Rate; Humans; Male; Middle Aged; Propofol; Retrospective Studies; Sodium Channels; Venlafaxine Hydrochloride	2002
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:3 Topics: Adult; Aged; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Venlafaxine Hydrochloride	2002